| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macular Degeneration | 35 | 2023 | 980 | 5.810 |
Why?
|
| Breast Neoplasms | 207 | 2024 | 20824 | 4.450 |
Why?
|
| Nurses | 102 | 2023 | 2462 | 3.010 |
Why?
|
| Diet | 121 | 2024 | 7937 | 2.730 |
Why?
|
| Models, Statistical | 56 | 2023 | 5101 | 2.620 |
Why?
|
| Premenopause | 47 | 2023 | 1033 | 2.270 |
Why?
|
| Risk Factors | 428 | 2024 | 72296 | 2.250 |
Why?
|
| Postmenopause | 65 | 2022 | 2460 | 2.230 |
Why?
|
| Menopause | 54 | 2022 | 1626 | 2.200 |
Why?
|
| Receptors, Progesterone | 24 | 2020 | 1098 | 2.150 |
Why?
|
| Glaucoma, Open-Angle | 26 | 2023 | 706 | 2.070 |
Why?
|
| Prospective Studies | 397 | 2023 | 53290 | 1.940 |
Why?
|
| Body Mass Index | 102 | 2022 | 12721 | 1.870 |
Why?
|
| Receptors, Estrogen | 26 | 2022 | 2190 | 1.820 |
Why?
|
| Statistics, Nonparametric | 13 | 2021 | 2887 | 1.810 |
Why?
|
| Retinitis Pigmentosa | 28 | 2018 | 386 | 1.810 |
Why?
|
| Blood Pressure | 76 | 2024 | 8551 | 1.750 |
Why?
|
| Dietary Fats | 44 | 2022 | 2016 | 1.690 |
Why?
|
| Female | 840 | 2024 | 380193 | 1.660 |
Why?
|
| Smoking | 113 | 2020 | 8987 | 1.620 |
Why?
|
| Middle Aged | 662 | 2024 | 213390 | 1.590 |
Why?
|
| Eye Diseases | 7 | 2020 | 669 | 1.550 |
Why?
|
| Biometry | 15 | 2019 | 558 | 1.520 |
Why?
|
| Carotenoids | 29 | 2022 | 624 | 1.500 |
Why?
|
| Diet Records | 21 | 2024 | 425 | 1.500 |
Why?
|
| Biostatistics | 4 | 2017 | 161 | 1.490 |
Why?
|
| Breast Diseases | 17 | 2021 | 443 | 1.470 |
Why?
|
| Alcohol Drinking | 61 | 2023 | 3966 | 1.460 |
Why?
|
| Feeding Behavior | 48 | 2021 | 3188 | 1.450 |
Why?
|
| Breast | 25 | 2023 | 1970 | 1.450 |
Why?
|
| Humans | 1053 | 2024 | 744366 | 1.430 |
Why?
|
| Adult | 651 | 2024 | 214052 | 1.400 |
Why?
|
| Complement Factor H | 15 | 2020 | 110 | 1.400 |
Why?
|
| Weight Gain | 26 | 2022 | 2293 | 1.380 |
Why?
|
| Retinal Drusen | 5 | 2020 | 66 | 1.370 |
Why?
|
| Follow-Up Studies | 208 | 2023 | 39052 | 1.370 |
Why?
|
| Mammography | 27 | 2024 | 2475 | 1.370 |
Why?
|
| Contact Lenses, Hydrophilic | 4 | 2022 | 64 | 1.350 |
Why?
|
| Hypertension | 73 | 2024 | 8479 | 1.330 |
Why?
|
| Contraceptives, Oral | 37 | 2021 | 564 | 1.310 |
Why?
|
| Regression Analysis | 55 | 2017 | 6459 | 1.300 |
Why?
|
| Proportional Hazards Models | 97 | 2023 | 12356 | 1.300 |
Why?
|
| Visual Acuity | 32 | 2020 | 2530 | 1.300 |
Why?
|
| Incidence | 151 | 2023 | 20952 | 1.290 |
Why?
|
| Ovarian Neoplasms | 38 | 2023 | 4839 | 1.210 |
Why?
|
| Risk Assessment | 71 | 2024 | 23336 | 1.200 |
Why?
|
| Polymorphism, Single Nucleotide | 38 | 2020 | 15520 | 1.150 |
Why?
|
| Parity | 31 | 2021 | 929 | 1.130 |
Why?
|
| Adiposity | 15 | 2022 | 1806 | 1.120 |
Why?
|
| Aged | 325 | 2024 | 163288 | 1.110 |
Why?
|
| Cluster Analysis | 9 | 2019 | 2715 | 1.100 |
Why?
|
| Case-Control Studies | 118 | 2023 | 21748 | 1.080 |
Why?
|
| Geographic Atrophy | 5 | 2018 | 66 | 1.060 |
Why?
|
| Diet Surveys | 36 | 2024 | 1173 | 1.020 |
Why?
|
| Visual Fields | 22 | 2022 | 1047 | 1.020 |
Why?
|
| Estrogen Replacement Therapy | 32 | 2018 | 1203 | 1.010 |
Why?
|
| Vegetables | 27 | 2021 | 1182 | 0.990 |
Why?
|
| Electroretinography | 17 | 2018 | 509 | 0.980 |
Why?
|
| Fruit | 27 | 2021 | 1142 | 0.980 |
Why?
|
| Longitudinal Studies | 71 | 2023 | 13991 | 0.970 |
Why?
|
| Data Interpretation, Statistical | 16 | 2018 | 2716 | 0.960 |
Why?
|
| Multivariate Analysis | 77 | 2021 | 12244 | 0.940 |
Why?
|
| Blood Pressure Determination | 20 | 2020 | 633 | 0.940 |
Why?
|
| Life Style | 31 | 2024 | 3835 | 0.930 |
Why?
|
| Antioxidants | 15 | 2018 | 1659 | 0.920 |
Why?
|
| Likelihood Functions | 12 | 2023 | 1005 | 0.910 |
Why?
|
| Nutrition Assessment | 11 | 2020 | 723 | 0.900 |
Why?
|
| Dietary Fiber | 19 | 2016 | 760 | 0.900 |
Why?
|
| Disease Progression | 31 | 2023 | 13286 | 0.890 |
Why?
|
| Diabetic Retinopathy | 8 | 2023 | 1210 | 0.880 |
Why?
|
| Male | 435 | 2024 | 350115 | 0.880 |
Why?
|
| Vitamin A | 23 | 2018 | 615 | 0.880 |
Why?
|
| Cohort Studies | 172 | 2023 | 40559 | 0.880 |
Why?
|
| Proteins | 14 | 2020 | 6100 | 0.870 |
Why?
|
| United States | 216 | 2023 | 69872 | 0.860 |
Why?
|
| Intraocular Pressure | 17 | 2022 | 1270 | 0.860 |
Why?
|
| Obesity | 44 | 2022 | 12746 | 0.850 |
Why?
|
| Anti-Mullerian Hormone | 7 | 2022 | 402 | 0.840 |
Why?
|
| Risk | 126 | 2020 | 9688 | 0.810 |
Why?
|
| Flavonoids | 7 | 2021 | 443 | 0.810 |
Why?
|
| Epidemiologic Methods | 22 | 2021 | 1364 | 0.800 |
Why?
|
| Energy Intake | 40 | 2022 | 2148 | 0.780 |
Why?
|
| Diet, Mediterranean | 10 | 2022 | 700 | 0.760 |
Why?
|
| Menopause, Premature | 6 | 2019 | 132 | 0.760 |
Why?
|
| Vision Disorders | 10 | 2022 | 1058 | 0.760 |
Why?
|
| Lymphoma, Non-Hodgkin | 9 | 2022 | 1381 | 0.760 |
Why?
|
| Nuts | 8 | 2021 | 257 | 0.760 |
Why?
|
| Hypertension, Pregnancy-Induced | 6 | 2022 | 489 | 0.750 |
Why?
|
| Reproductive History | 9 | 2021 | 209 | 0.750 |
Why?
|
| Age Factors | 119 | 2021 | 18373 | 0.750 |
Why?
|
| Body Weight | 42 | 2019 | 4671 | 0.750 |
Why?
|
| Menarche | 18 | 2023 | 516 | 0.730 |
Why?
|
| ROC Curve | 14 | 2023 | 3528 | 0.720 |
Why?
|
| Ophthalmoscopy | 1 | 2020 | 176 | 0.720 |
Why?
|
| Fatty Acids, Omega-3 | 14 | 2022 | 1344 | 0.710 |
Why?
|
| Lutein | 8 | 2013 | 125 | 0.710 |
Why?
|
| Trans Fatty Acids | 5 | 2022 | 153 | 0.710 |
Why?
|
| Vitamin D | 13 | 2022 | 3224 | 0.710 |
Why?
|
| Colorectal Neoplasms | 24 | 2023 | 6773 | 0.700 |
Why?
|
| Disease Susceptibility | 5 | 2020 | 1782 | 0.690 |
Why?
|
| Diabetes Mellitus, Type 2 | 37 | 2023 | 11726 | 0.690 |
Why?
|
| Adolescent | 181 | 2024 | 85779 | 0.680 |
Why?
|
| Survival Analysis | 20 | 2023 | 10252 | 0.680 |
Why?
|
| Optic Neuritis | 1 | 2021 | 166 | 0.670 |
Why?
|
| Exercise | 30 | 2023 | 5615 | 0.670 |
Why?
|
| Cataract | 21 | 2023 | 834 | 0.670 |
Why?
|
| Endometrial Neoplasms | 11 | 2023 | 1351 | 0.660 |
Why?
|
| Folic Acid | 16 | 2019 | 1300 | 0.650 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2017 | 213 | 0.640 |
Why?
|
| Odds Ratio | 51 | 2022 | 9849 | 0.620 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 5 | 2021 | 236 | 0.620 |
Why?
|
| Nutrition Surveys | 16 | 2020 | 1660 | 0.610 |
Why?
|
| Research Design | 21 | 2022 | 5984 | 0.610 |
Why?
|
| Breast Feeding | 10 | 2021 | 1338 | 0.610 |
Why?
|
| Piriformis Muscle Syndrome | 1 | 2017 | 3 | 0.610 |
Why?
|
| Genetic Predisposition to Disease | 28 | 2021 | 17446 | 0.610 |
Why?
|
| Sterilization, Tubal | 7 | 2021 | 87 | 0.600 |
Why?
|
| Complement C3 | 8 | 2020 | 461 | 0.590 |
Why?
|
| Caffeine | 9 | 2019 | 699 | 0.570 |
Why?
|
| Cause of Death | 19 | 2021 | 3582 | 0.570 |
Why?
|
| Logistic Models | 49 | 2022 | 13409 | 0.570 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 13 | 2021 | 2282 | 0.560 |
Why?
|
| Zinc Compounds | 1 | 2016 | 35 | 0.560 |
Why?
|
| Ascorbic Acid | 10 | 2022 | 651 | 0.560 |
Why?
|
| Retina | 9 | 2021 | 2616 | 0.550 |
Why?
|
| Dietary Carbohydrates | 11 | 2021 | 905 | 0.550 |
Why?
|
| Computer Simulation | 13 | 2023 | 6194 | 0.550 |
Why?
|
| Genotype | 33 | 2018 | 12952 | 0.540 |
Why?
|
| Estrogens | 21 | 2021 | 1566 | 0.540 |
Why?
|
| Coffee | 9 | 2021 | 578 | 0.530 |
Why?
|
| Retinopathy of Prematurity | 1 | 2020 | 421 | 0.530 |
Why?
|
| Cardiovascular Diseases | 45 | 2022 | 15160 | 0.530 |
Why?
|
| Diabetes, Gestational | 8 | 2022 | 1184 | 0.530 |
Why?
|
| Vitamin B Complex | 6 | 2019 | 288 | 0.530 |
Why?
|
| Coronary Disease | 45 | 2022 | 6077 | 0.530 |
Why?
|
| Time Factors | 94 | 2020 | 40075 | 0.520 |
Why?
|
| Fish Products | 2 | 2006 | 29 | 0.520 |
Why?
|
| Anthropometry | 14 | 2022 | 1350 | 0.520 |
Why?
|
| Collagen Type VIII | 2 | 2016 | 15 | 0.520 |
Why?
|
| Diseases in Twins | 2 | 2008 | 449 | 0.520 |
Why?
|
| Refractive Errors | 2 | 2017 | 142 | 0.520 |
Why?
|
| Neuromuscular Agents | 1 | 2017 | 134 | 0.520 |
Why?
|
| Ovulation | 8 | 2009 | 189 | 0.510 |
Why?
|
| Aspirin | 23 | 2021 | 3283 | 0.510 |
Why?
|
| Area Under Curve | 10 | 2021 | 1655 | 0.500 |
Why?
|
| Chronic Disease | 14 | 2020 | 9145 | 0.500 |
Why?
|
| Aged, 80 and over | 76 | 2021 | 57776 | 0.500 |
Why?
|
| Health Personnel | 19 | 2019 | 3219 | 0.500 |
Why?
|
| Work Schedule Tolerance | 7 | 2019 | 563 | 0.500 |
Why?
|
| Lipase | 3 | 2011 | 314 | 0.490 |
Why?
|
| Anion Exchange Resins | 1 | 2014 | 10 | 0.490 |
Why?
|
| Colestipol | 1 | 2014 | 10 | 0.490 |
Why?
|
| Imidazolidines | 3 | 2004 | 39 | 0.490 |
Why?
|
| Hysterectomy | 9 | 2013 | 927 | 0.480 |
Why?
|
| Pregnancy | 70 | 2023 | 29144 | 0.480 |
Why?
|
| Dietary Supplements | 21 | 2022 | 3296 | 0.480 |
Why?
|
| Prolactin | 8 | 2018 | 669 | 0.480 |
Why?
|
| Pre-Eclampsia | 6 | 2022 | 1200 | 0.480 |
Why?
|
| beta Carotene | 16 | 2015 | 527 | 0.470 |
Why?
|
| Macula Lutea | 1 | 2015 | 151 | 0.470 |
Why?
|
| Ophthalmology | 6 | 2017 | 508 | 0.470 |
Why?
|
| Waist Circumference | 7 | 2022 | 917 | 0.460 |
Why?
|
| Eating | 11 | 2022 | 1536 | 0.460 |
Why?
|
| Environment | 6 | 2015 | 1123 | 0.460 |
Why?
|
| Body Constitution | 6 | 2003 | 278 | 0.460 |
Why?
|
| Protoporphyria, Erythropoietic | 1 | 2014 | 43 | 0.460 |
Why?
|
| Twins, Monozygotic | 5 | 2011 | 458 | 0.460 |
Why?
|
| Models, Theoretical | 8 | 2019 | 3589 | 0.450 |
Why?
|
| Confidence Intervals | 21 | 2020 | 2971 | 0.440 |
Why?
|
| Physical Therapy Modalities | 1 | 2017 | 550 | 0.440 |
Why?
|
| Tomography, Optical Coherence | 6 | 2021 | 2657 | 0.440 |
Why?
|
| Insulin-Like Growth Factor I | 9 | 2014 | 2016 | 0.440 |
Why?
|
| Food | 7 | 2024 | 772 | 0.440 |
Why?
|
| Dairy Products | 7 | 2019 | 498 | 0.440 |
Why?
|
| Colonic Neoplasms | 9 | 2018 | 2542 | 0.430 |
Why?
|
| Self Report | 13 | 2019 | 3553 | 0.430 |
Why?
|
| Models, Biological | 14 | 2018 | 9584 | 0.430 |
Why?
|
| Eggs | 5 | 2020 | 184 | 0.430 |
Why?
|
| Bayes Theorem | 2 | 2018 | 2307 | 0.420 |
Why?
|
| Mammary Glands, Human | 6 | 2015 | 199 | 0.420 |
Why?
|
| Resource Allocation | 1 | 2014 | 341 | 0.420 |
Why?
|
| Vitamins | 15 | 2022 | 1623 | 0.420 |
Why?
|
| Gonadal Steroid Hormones | 6 | 2019 | 711 | 0.420 |
Why?
|
| Smoking Cessation | 15 | 2018 | 2071 | 0.420 |
Why?
|
| Algorithms | 14 | 2023 | 13882 | 0.420 |
Why?
|
| Infertility, Female | 10 | 2015 | 788 | 0.420 |
Why?
|
| Diet Therapy | 3 | 2021 | 154 | 0.410 |
Why?
|
| Reproducibility of Results | 39 | 2024 | 19905 | 0.410 |
Why?
|
| Body Size | 5 | 2022 | 461 | 0.410 |
Why?
|
| Dietary Proteins | 8 | 2022 | 963 | 0.410 |
Why?
|
| Women's Health | 16 | 2024 | 2034 | 0.410 |
Why?
|
| Meat | 8 | 2023 | 592 | 0.400 |
Why?
|
| Neoplasms, Glandular and Epithelial | 5 | 2014 | 484 | 0.400 |
Why?
|
| Railroads | 3 | 2006 | 61 | 0.390 |
Why?
|
| Birth Weight | 11 | 2022 | 2069 | 0.390 |
Why?
|
| Betaine | 1 | 2011 | 87 | 0.390 |
Why?
|
| Child | 106 | 2023 | 77709 | 0.390 |
Why?
|
| Nutritional Status | 5 | 2018 | 1609 | 0.380 |
Why?
|
| Methionine | 4 | 2013 | 590 | 0.380 |
Why?
|
| Fibrocystic Breast Disease | 5 | 2013 | 102 | 0.380 |
Why?
|
| Testosterone | 10 | 2019 | 2419 | 0.380 |
Why?
|
| Matched-Pair Analysis | 2 | 2006 | 288 | 0.380 |
Why?
|
| Health Surveys | 25 | 2020 | 4036 | 0.380 |
Why?
|
| Prognosis | 38 | 2022 | 29060 | 0.370 |
Why?
|
| Wet Macular Degeneration | 3 | 2017 | 145 | 0.370 |
Why?
|
| Vitamin E | 19 | 2009 | 869 | 0.370 |
Why?
|
| Exfoliation Syndrome | 2 | 2022 | 110 | 0.370 |
Why?
|
| Mothers | 11 | 2022 | 2165 | 0.370 |
Why?
|
| Sex Factors | 46 | 2019 | 10400 | 0.370 |
Why?
|
| Telomere | 5 | 2019 | 910 | 0.370 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 6 | 2014 | 424 | 0.360 |
Why?
|
| Estradiol | 11 | 2019 | 2020 | 0.360 |
Why?
|
| Motor Activity | 9 | 2018 | 2715 | 0.350 |
Why?
|
| Carbon | 5 | 2019 | 687 | 0.350 |
Why?
|
| Serine Endopeptidases | 3 | 2016 | 1073 | 0.340 |
Why?
|
| Demography | 6 | 2023 | 1655 | 0.340 |
Why?
|
| Body Height | 19 | 2020 | 1578 | 0.340 |
Why?
|
| Complement C2 | 5 | 2016 | 72 | 0.340 |
Why?
|
| Young Adult | 55 | 2024 | 56429 | 0.340 |
Why?
|
| Linear Models | 20 | 2020 | 5953 | 0.340 |
Why?
|
| Complement Factor B | 5 | 2016 | 72 | 0.340 |
Why?
|
| Alcoholic Beverages | 8 | 2023 | 265 | 0.340 |
Why?
|
| Environmental Exposure | 5 | 2023 | 4232 | 0.340 |
Why?
|
| C-Reactive Protein | 6 | 2019 | 3778 | 0.330 |
Why?
|
| Vehicle Emissions | 4 | 2008 | 665 | 0.330 |
Why?
|
| Delirium | 4 | 2023 | 1610 | 0.330 |
Why?
|
| Sample Size | 5 | 2022 | 845 | 0.320 |
Why?
|
| Age of Onset | 8 | 2020 | 3270 | 0.320 |
Why?
|
| Multiple Myeloma | 8 | 2022 | 5181 | 0.320 |
Why?
|
| Nutritional Physiological Phenomena | 7 | 2017 | 370 | 0.320 |
Why?
|
| Fatty Acids | 10 | 2022 | 1809 | 0.320 |
Why?
|
| Choroidal Neovascularization | 3 | 2018 | 343 | 0.320 |
Why?
|
| Video Games | 3 | 2016 | 184 | 0.320 |
Why?
|
| Apolipoprotein C-III | 2 | 2021 | 202 | 0.320 |
Why?
|
| Carbonated Beverages | 4 | 2021 | 214 | 0.310 |
Why?
|
| Gestational Age | 4 | 2022 | 3493 | 0.310 |
Why?
|
| Lens, Crystalline | 5 | 2022 | 388 | 0.310 |
Why?
|
| Food, Fortified | 3 | 2020 | 191 | 0.310 |
Why?
|
| Television | 3 | 2016 | 409 | 0.310 |
Why?
|
| Aldosterone | 3 | 2024 | 877 | 0.310 |
Why?
|
| Tea | 3 | 2021 | 275 | 0.300 |
Why?
|
| Tobacco Use Disorder | 2 | 2011 | 688 | 0.300 |
Why?
|
| Overweight | 7 | 2021 | 2371 | 0.300 |
Why?
|
| Insulin Resistance | 4 | 2022 | 3864 | 0.300 |
Why?
|
| Progestins | 8 | 2021 | 306 | 0.300 |
Why?
|
| Cognition Disorders | 9 | 2016 | 4043 | 0.290 |
Why?
|
| CA-125 Antigen | 2 | 2019 | 286 | 0.290 |
Why?
|
| Leukocytes | 5 | 2018 | 2045 | 0.290 |
Why?
|
| Predictive Value of Tests | 21 | 2020 | 15078 | 0.290 |
Why?
|
| Vitamin B 12 | 5 | 2019 | 527 | 0.280 |
Why?
|
| Receptor, erbB-2 | 7 | 2019 | 2417 | 0.280 |
Why?
|
| Population Surveillance | 12 | 2019 | 2616 | 0.280 |
Why?
|
| Scotoma | 3 | 2021 | 139 | 0.280 |
Why?
|
| Xanthophylls | 7 | 2013 | 96 | 0.280 |
Why?
|
| Prevalence | 23 | 2019 | 15221 | 0.280 |
Why?
|
| Disease Management | 1 | 2017 | 2460 | 0.280 |
Why?
|
| Aging | 28 | 2019 | 8664 | 0.280 |
Why?
|
| Carcinoma, Lobular | 1 | 2010 | 484 | 0.280 |
Why?
|
| Calcium, Dietary | 7 | 2017 | 526 | 0.280 |
Why?
|
| Phenotype | 16 | 2021 | 16367 | 0.280 |
Why?
|
| Lipoproteins, HDL | 6 | 2021 | 638 | 0.270 |
Why?
|
| Biomedical Research | 4 | 2019 | 3309 | 0.270 |
Why?
|
| Health Status | 5 | 2019 | 4034 | 0.270 |
Why?
|
| Weight Loss | 7 | 2019 | 2625 | 0.270 |
Why?
|
| Milk | 3 | 2018 | 450 | 0.270 |
Why?
|
| Starch | 2 | 2016 | 81 | 0.270 |
Why?
|
| Lung Diseases, Obstructive | 9 | 1998 | 316 | 0.270 |
Why?
|
| Mass Screening | 12 | 2015 | 5253 | 0.270 |
Why?
|
| Periodontitis | 2 | 2021 | 553 | 0.260 |
Why?
|
| Otitis Media with Effusion | 4 | 2000 | 114 | 0.260 |
Why?
|
| Estrogens, Conjugated (USP) | 3 | 2017 | 275 | 0.260 |
Why?
|
| Therapeutics | 1 | 2006 | 116 | 0.260 |
Why?
|
| Cholesterol, HDL | 14 | 2022 | 1813 | 0.260 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2010 | 1100 | 0.260 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2008 | 302 | 0.260 |
Why?
|
| DNA | 4 | 2016 | 7294 | 0.260 |
Why?
|
| Porphyria, Hepatoerythropoietic | 2 | 2002 | 8 | 0.260 |
Why?
|
| Vitamin B 6 | 4 | 2013 | 237 | 0.260 |
Why?
|
| Hormones | 3 | 2018 | 889 | 0.260 |
Why?
|
| Sciatica | 2 | 2002 | 98 | 0.260 |
Why?
|
| Isoflavones | 2 | 2016 | 139 | 0.260 |
Why?
|
| Adult Children | 2 | 2019 | 100 | 0.260 |
Why?
|
| Analgesics | 6 | 2018 | 1040 | 0.250 |
Why?
|
| Anovulation | 4 | 2009 | 58 | 0.250 |
Why?
|
| Cross-Sectional Studies | 37 | 2023 | 25039 | 0.250 |
Why?
|
| Prostatitis | 2 | 2015 | 102 | 0.250 |
Why?
|
| Counseling | 3 | 2012 | 1523 | 0.250 |
Why?
|
| Menstrual Cycle | 4 | 2019 | 551 | 0.250 |
Why?
|
| Triglycerides | 16 | 2022 | 2453 | 0.250 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2021 | 857 | 0.250 |
Why?
|
| Cognition | 9 | 2019 | 6770 | 0.250 |
Why?
|
| Photosensitivity Disorders | 2 | 2002 | 78 | 0.250 |
Why?
|
| Estrogen Receptor alpha | 3 | 2018 | 577 | 0.250 |
Why?
|
| Principal Component Analysis | 3 | 2023 | 940 | 0.240 |
Why?
|
| Family | 8 | 2012 | 3147 | 0.240 |
Why?
|
| Phobic Disorders | 2 | 2018 | 439 | 0.240 |
Why?
|
| Estrone | 5 | 2018 | 240 | 0.240 |
Why?
|
| Genetic Variation | 7 | 2020 | 6542 | 0.240 |
Why?
|
| Lipids | 7 | 2019 | 3307 | 0.240 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2019 | 284 | 0.240 |
Why?
|
| Erythrocyte Membrane | 4 | 2020 | 442 | 0.240 |
Why?
|
| Depression | 6 | 2024 | 7759 | 0.230 |
Why?
|
| Health Behavior | 4 | 2017 | 2635 | 0.230 |
Why?
|
| Transportation | 2 | 2020 | 214 | 0.230 |
Why?
|
| Ethanol | 10 | 2023 | 1342 | 0.230 |
Why?
|
| Salmonella Food Poisoning | 2 | 2014 | 14 | 0.230 |
Why?
|
| Circadian Rhythm | 4 | 2024 | 2624 | 0.230 |
Why?
|
| Minerals | 2 | 2016 | 275 | 0.230 |
Why?
|
| Cholesterol | 21 | 2020 | 2919 | 0.230 |
Why?
|
| Seasons | 3 | 2018 | 1493 | 0.230 |
Why?
|
| Analysis of Variance | 28 | 2004 | 6366 | 0.230 |
Why?
|
| Child Welfare | 1 | 2008 | 523 | 0.230 |
Why?
|
| Sodium, Dietary | 3 | 2020 | 418 | 0.230 |
Why?
|
| Cysteine | 4 | 2019 | 873 | 0.230 |
Why?
|
| Epidemiologic Studies | 4 | 2023 | 676 | 0.230 |
Why?
|
| Age Distribution | 9 | 2018 | 2902 | 0.230 |
Why?
|
| Adenoma | 7 | 2016 | 2174 | 0.230 |
Why?
|
| Fatty Acids, Monounsaturated | 4 | 2022 | 194 | 0.230 |
Why?
|
| Statistics as Topic | 15 | 2018 | 2373 | 0.220 |
Why?
|
| Genetic Association Studies | 3 | 2015 | 2703 | 0.220 |
Why?
|
| Hormone Replacement Therapy | 4 | 2009 | 745 | 0.220 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2019 | 783 | 0.220 |
Why?
|
| Telemedicine | 1 | 2020 | 2872 | 0.220 |
Why?
|
| Infant, Newborn | 30 | 2022 | 25628 | 0.220 |
Why?
|
| H-Reflex | 3 | 2017 | 26 | 0.220 |
Why?
|
| Hair Dyes | 3 | 2020 | 30 | 0.220 |
Why?
|
| Pelvic Pain | 2 | 2015 | 274 | 0.220 |
Why?
|
| Docosahexaenoic Acids | 7 | 2017 | 875 | 0.220 |
Why?
|
| Diet, Carbohydrate-Restricted | 2 | 2023 | 262 | 0.220 |
Why?
|
| Uveitis, Anterior | 1 | 2023 | 101 | 0.220 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 1956 | 0.220 |
Why?
|
| Pubic Symphysis | 1 | 2022 | 21 | 0.220 |
Why?
|
| Mental Recall | 7 | 2021 | 1206 | 0.220 |
Why?
|
| Double-Blind Method | 29 | 2018 | 12025 | 0.220 |
Why?
|
| Risk Reduction Behavior | 6 | 2021 | 1125 | 0.220 |
Why?
|
| Blood Glucose | 12 | 2020 | 6254 | 0.220 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2022 | 2408 | 0.210 |
Why?
|
| Infant | 25 | 2022 | 35134 | 0.210 |
Why?
|
| Receptors, Androgen | 3 | 2019 | 1058 | 0.210 |
Why?
|
| Metabolomics | 5 | 2022 | 1485 | 0.210 |
Why?
|
| Severity of Illness Index | 9 | 2020 | 15535 | 0.210 |
Why?
|
| Polymorphism, Genetic | 5 | 2008 | 4328 | 0.210 |
Why?
|
| gamma-Tocopherol | 1 | 2022 | 31 | 0.210 |
Why?
|
| Cortisone | 1 | 2022 | 89 | 0.210 |
Why?
|
| Mouth Neoplasms | 4 | 2010 | 601 | 0.210 |
Why?
|
| Occupational Diseases | 5 | 2006 | 1469 | 0.210 |
Why?
|
| Dehydroepiandrosterone Sulfate | 4 | 2019 | 238 | 0.210 |
Why?
|
| Chromatography, Liquid | 5 | 2023 | 976 | 0.210 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 2021 | 251 | 0.210 |
Why?
|
| Diethylstilbestrol | 1 | 2022 | 93 | 0.210 |
Why?
|
| Early Detection of Cancer | 6 | 2022 | 3086 | 0.210 |
Why?
|
| Tissue Array Analysis | 7 | 2021 | 553 | 0.210 |
Why?
|
| Occupational Exposure | 3 | 2008 | 1793 | 0.200 |
Why?
|
| Neoplasms | 28 | 2023 | 21696 | 0.200 |
Why?
|
| Acrylamide | 2 | 2013 | 60 | 0.200 |
Why?
|
| Homocysteine | 4 | 2019 | 647 | 0.200 |
Why?
|
| Prader-Willi Syndrome | 2 | 1999 | 79 | 0.200 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2003 | 204 | 0.200 |
Why?
|
| Diet, Vegetarian | 3 | 2021 | 174 | 0.200 |
Why?
|
| Complement System Proteins | 2 | 2018 | 795 | 0.200 |
Why?
|
| Body Composition | 5 | 2015 | 2402 | 0.200 |
Why?
|
| Eye Proteins | 3 | 2018 | 645 | 0.200 |
Why?
|
| Taste | 1 | 2002 | 176 | 0.200 |
Why?
|
| Mortality | 11 | 2019 | 2864 | 0.200 |
Why?
|
| Sex Hormone-Binding Globulin | 5 | 2019 | 548 | 0.200 |
Why?
|
| Patient Compliance | 10 | 2018 | 2684 | 0.190 |
Why?
|
| Europe | 6 | 2020 | 3338 | 0.190 |
Why?
|
| Pyridoxal Phosphate | 2 | 2019 | 127 | 0.190 |
Why?
|
| Seafood | 4 | 2019 | 384 | 0.190 |
Why?
|
| Health Promotion | 4 | 2020 | 2205 | 0.190 |
Why?
|
| Cataract Extraction | 8 | 2002 | 481 | 0.190 |
Why?
|
| Asthma | 14 | 2015 | 6010 | 0.190 |
Why?
|
| Systole | 11 | 2019 | 958 | 0.190 |
Why?
|
| Tandem Mass Spectrometry | 6 | 2023 | 1157 | 0.190 |
Why?
|
| Electrodiagnosis | 2 | 2017 | 151 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 19 | 2018 | 10943 | 0.190 |
Why?
|
| Drinking Behavior | 1 | 2021 | 103 | 0.190 |
Why?
|
| Respiratory Tract Diseases | 6 | 2010 | 722 | 0.190 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 2020 | 500 | 0.190 |
Why?
|
| Williams Syndrome | 2 | 2001 | 187 | 0.190 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2020 | 3255 | 0.190 |
Why?
|
| Dietary Fats, Unsaturated | 6 | 2007 | 226 | 0.180 |
Why?
|
| Relief Work | 1 | 2022 | 137 | 0.180 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2020 | 30 | 0.180 |
Why?
|
| Occupational Health | 3 | 2020 | 808 | 0.180 |
Why?
|
| Family Health | 6 | 2011 | 1281 | 0.180 |
Why?
|
| Occult Blood | 1 | 2001 | 176 | 0.180 |
Why?
|
| Ownership | 1 | 2022 | 332 | 0.180 |
Why?
|
| Calibration | 2 | 2022 | 816 | 0.180 |
Why?
|
| Sodium Chloride | 1 | 2002 | 625 | 0.180 |
Why?
|
| Rhodopsin | 7 | 2008 | 203 | 0.180 |
Why?
|
| Pseudouridine | 1 | 2020 | 24 | 0.180 |
Why?
|
| Colonic Polyps | 2 | 2023 | 542 | 0.180 |
Why?
|
| Urinary Tract Infections | 5 | 1989 | 788 | 0.180 |
Why?
|
| Child, Preschool | 46 | 2022 | 41005 | 0.180 |
Why?
|
| Uveitis | 1 | 2023 | 375 | 0.180 |
Why?
|
| Melatonin | 3 | 2019 | 721 | 0.180 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2022 | 257 | 0.170 |
Why?
|
| Maternal Age | 9 | 2006 | 802 | 0.170 |
Why?
|
| Tobacco Smoke Pollution | 6 | 2011 | 816 | 0.170 |
Why?
|
| Nutritive Value | 3 | 2019 | 339 | 0.170 |
Why?
|
| Hyperinsulinism | 1 | 2022 | 415 | 0.170 |
Why?
|
| Myocardial Infarction | 31 | 2021 | 11718 | 0.170 |
Why?
|
| Plant Oils | 4 | 2023 | 202 | 0.170 |
Why?
|
| Prostatic Neoplasms | 7 | 2021 | 11126 | 0.170 |
Why?
|
| Uterus | 2 | 2022 | 711 | 0.170 |
Why?
|
| Reference Values | 10 | 2018 | 4982 | 0.170 |
Why?
|
| Thromboembolism | 2 | 2005 | 987 | 0.170 |
Why?
|
| Hip Fractures | 3 | 2018 | 955 | 0.170 |
Why?
|
| Cerebrovascular Disorders | 14 | 1999 | 1504 | 0.170 |
Why?
|
| Hyperlipidemias | 2 | 2019 | 789 | 0.170 |
Why?
|
| Hypercholesterolemia | 5 | 2019 | 1151 | 0.170 |
Why?
|
| Osteoarthritis, Hip | 1 | 2023 | 412 | 0.170 |
Why?
|
| Behavior Therapy | 3 | 2014 | 865 | 0.170 |
Why?
|
| Urinary Incontinence | 3 | 2008 | 496 | 0.170 |
Why?
|
| Caveolin 1 | 1 | 2020 | 263 | 0.160 |
Why?
|
| Nutrition Policy | 3 | 2016 | 488 | 0.160 |
Why?
|
| Forced Expiratory Volume | 16 | 2002 | 1745 | 0.160 |
Why?
|
| Flour | 1 | 2018 | 19 | 0.160 |
Why?
|
| Cyclooxygenase 1 | 1 | 2018 | 104 | 0.160 |
Why?
|
| alpha-Linolenic Acid | 2 | 2017 | 144 | 0.160 |
Why?
|
| Models, Genetic | 2 | 2008 | 3493 | 0.160 |
Why?
|
| Magnesium | 8 | 2016 | 813 | 0.160 |
Why?
|
| Personality Development | 1 | 1999 | 245 | 0.160 |
Why?
|
| Oils | 1 | 2018 | 63 | 0.160 |
Why?
|
| Triticum | 1 | 2018 | 86 | 0.160 |
Why?
|
| Acetaminophen | 7 | 2012 | 545 | 0.160 |
Why?
|
| Chronobiology Disorders | 1 | 2019 | 74 | 0.160 |
Why?
|
| Phenylhydrazines | 1 | 2018 | 28 | 0.160 |
Why?
|
| Anticarcinogenic Agents | 3 | 2014 | 253 | 0.160 |
Why?
|
| Probability | 7 | 2021 | 2506 | 0.160 |
Why?
|
| Boston | 29 | 2019 | 9312 | 0.160 |
Why?
|
| Potassium | 7 | 2016 | 1336 | 0.160 |
Why?
|
| Deficiency Diseases | 1 | 2018 | 72 | 0.160 |
Why?
|
| Succinimides | 1 | 2018 | 79 | 0.160 |
Why?
|
| Carcinoma, Endometrioid | 3 | 2016 | 271 | 0.160 |
Why?
|
| Proxy | 1 | 2019 | 145 | 0.160 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2019 | 357 | 0.150 |
Why?
|
| Indenes | 1 | 2018 | 57 | 0.150 |
Why?
|
| Skin Neoplasms | 9 | 2020 | 5692 | 0.150 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2018 | 115 | 0.150 |
Why?
|
| Catheters, Indwelling | 5 | 1989 | 426 | 0.150 |
Why?
|
| Adrenal Glands | 1 | 2020 | 546 | 0.150 |
Why?
|
| Depressive Disorder | 4 | 2019 | 3747 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2006 | 9955 | 0.150 |
Why?
|
| Markov Chains | 2 | 2012 | 969 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2006 | 3338 | 0.150 |
Why?
|
| Adenocarcinoma, Clear Cell | 2 | 2016 | 221 | 0.150 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2011 | 689 | 0.150 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2016 | 1581 | 0.150 |
Why?
|
| Diastole | 8 | 2000 | 791 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 3 | 2019 | 6171 | 0.150 |
Why?
|
| Dyslipidemias | 2 | 2020 | 849 | 0.150 |
Why?
|
| Cerebellar Neoplasms | 1 | 2022 | 587 | 0.150 |
Why?
|
| Interleukin-6 | 4 | 2019 | 3203 | 0.150 |
Why?
|
| Trichomonas Infections | 1 | 2017 | 43 | 0.150 |
Why?
|
| Lung Neoplasms | 10 | 2020 | 13104 | 0.150 |
Why?
|
| Ovary | 6 | 2019 | 981 | 0.150 |
Why?
|
| Hydrocortisone | 7 | 2019 | 1826 | 0.150 |
Why?
|
| Asymptomatic Diseases | 1 | 2020 | 551 | 0.150 |
Why?
|
| Adenocarcinoma | 4 | 2013 | 6364 | 0.150 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 501 | 0.150 |
Why?
|
| Stroke | 9 | 2019 | 9981 | 0.150 |
Why?
|
| Cross Infection | 6 | 1989 | 1417 | 0.140 |
Why?
|
| Glaucoma | 2 | 2020 | 1159 | 0.140 |
Why?
|
| Medulloblastoma | 1 | 2022 | 683 | 0.140 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2017 | 163 | 0.140 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2018 | 177 | 0.140 |
Why?
|
| Food Preferences | 3 | 2018 | 399 | 0.140 |
Why?
|
| Femoral Neck Fractures | 1 | 2018 | 138 | 0.140 |
Why?
|
| Calcium | 6 | 2017 | 5755 | 0.140 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2008 | 504 | 0.140 |
Why?
|
| Musculoskeletal System | 1 | 2019 | 175 | 0.140 |
Why?
|
| Stress, Psychological | 5 | 2019 | 4245 | 0.140 |
Why?
|
| Dinoprostone | 1 | 2019 | 601 | 0.140 |
Why?
|
| beta-Carotene 15,15'-Monooxygenase | 2 | 2013 | 12 | 0.140 |
Why?
|
| Somatotypes | 1 | 2016 | 42 | 0.140 |
Why?
|
| Colonoscopy | 5 | 2023 | 1367 | 0.140 |
Why?
|
| Cholesterol, LDL | 13 | 2022 | 2355 | 0.140 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 9647 | 0.140 |
Why?
|
| Soy Foods | 1 | 2016 | 48 | 0.140 |
Why?
|
| Voice Disorders | 1 | 2019 | 276 | 0.140 |
Why?
|
| Pregnancy Complications | 5 | 2021 | 2861 | 0.140 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2022 | 967 | 0.140 |
Why?
|
| Pregnancy, Animal | 1 | 2016 | 134 | 0.140 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 1239 | 0.140 |
Why?
|
| Blood Specimen Collection | 2 | 2017 | 246 | 0.140 |
Why?
|
| Reproduction | 5 | 2019 | 668 | 0.140 |
Why?
|
| Adipose Tissue | 8 | 2021 | 3280 | 0.140 |
Why?
|
| Rectal Neoplasms | 4 | 2017 | 1205 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 1 | 2018 | 612 | 0.140 |
Why?
|
| Twins | 4 | 2010 | 339 | 0.140 |
Why?
|
| Electrolytes | 1 | 2016 | 282 | 0.130 |
Why?
|
| Ceramides | 1 | 2017 | 199 | 0.130 |
Why?
|
| Emigrants and Immigrants | 1 | 2022 | 522 | 0.130 |
Why?
|
| Milk, Human | 1 | 2020 | 490 | 0.130 |
Why?
|
| Semen Analysis | 1 | 2017 | 204 | 0.130 |
Why?
|
| Otitis Media | 4 | 1997 | 277 | 0.130 |
Why?
|
| Clinical Trials as Topic | 15 | 2013 | 7914 | 0.130 |
Why?
|
| Nonsteroidal Anti-Androgens | 1 | 2015 | 8 | 0.130 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2016 | 124 | 0.130 |
Why?
|
| Fish Oils | 3 | 2013 | 470 | 0.130 |
Why?
|
| Treatment Outcome | 21 | 2020 | 63107 | 0.130 |
Why?
|
| Socioeconomic Factors | 11 | 2019 | 7785 | 0.130 |
Why?
|
| Personnel Staffing and Scheduling | 3 | 2016 | 500 | 0.130 |
Why?
|
| Registries | 9 | 2022 | 8091 | 0.130 |
Why?
|
| Retrospective Studies | 34 | 2023 | 77460 | 0.130 |
Why?
|
| Sleep Deprivation | 3 | 2023 | 832 | 0.130 |
Why?
|
| Self Care | 2 | 2012 | 786 | 0.130 |
Why?
|
| Citrullus | 1 | 2014 | 4 | 0.130 |
Why?
|
| Platinum | 1 | 2016 | 233 | 0.130 |
Why?
|
| Micronutrients | 4 | 2021 | 375 | 0.130 |
Why?
|
| Nitrates | 2 | 2016 | 265 | 0.130 |
Why?
|
| Sex Distribution | 4 | 2018 | 2297 | 0.130 |
Why?
|
| Keloid | 1 | 2015 | 50 | 0.120 |
Why?
|
| Phosphatidylethanolamines | 4 | 2022 | 134 | 0.120 |
Why?
|
| Refugees | 1 | 2022 | 511 | 0.120 |
Why?
|
| Gene Expression | 5 | 2016 | 7798 | 0.120 |
Why?
|
| Sensitivity and Specificity | 10 | 2020 | 14723 | 0.120 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2014 | 58 | 0.120 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2017 | 582 | 0.120 |
Why?
|
| Motivation | 2 | 2008 | 1971 | 0.120 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2014 | 141 | 0.120 |
Why?
|
| Phenols | 2 | 2016 | 497 | 0.120 |
Why?
|
| Beverages | 5 | 2021 | 821 | 0.120 |
Why?
|
| Twins, Dizygotic | 4 | 2006 | 236 | 0.120 |
Why?
|
| Urinalysis | 1 | 2016 | 369 | 0.120 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2018 | 841 | 0.120 |
Why?
|
| Epidemiology | 1 | 1997 | 287 | 0.120 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2014 | 134 | 0.120 |
Why?
|
| Lens Cortex, Crystalline | 1 | 1993 | 21 | 0.120 |
Why?
|
| Infertility, Male | 1 | 2017 | 409 | 0.120 |
Why?
|
| Lens Nucleus, Crystalline | 1 | 1993 | 32 | 0.120 |
Why?
|
| Disease-Free Survival | 2 | 2022 | 6896 | 0.120 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 198 | 0.120 |
Why?
|
| Fovea Centralis | 1 | 2014 | 119 | 0.120 |
Why?
|
| Thinness | 1 | 2017 | 480 | 0.120 |
Why?
|
| Salmonella | 1 | 2014 | 129 | 0.120 |
Why?
|
| Carbohydrates | 2 | 2020 | 394 | 0.120 |
Why?
|
| Alleles | 5 | 2020 | 6933 | 0.120 |
Why?
|
| Sigmoidoscopy | 2 | 2013 | 156 | 0.120 |
Why?
|
| Air Pollutants | 3 | 2023 | 2816 | 0.120 |
Why?
|
| Models, Economic | 1 | 2018 | 712 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2015 | 1856 | 0.120 |
Why?
|
| Myoblasts, Skeletal | 1 | 2014 | 76 | 0.120 |
Why?
|
| Terminal Repeat Sequences | 1 | 2013 | 72 | 0.120 |
Why?
|
| Disease Outbreaks | 2 | 2014 | 1771 | 0.110 |
Why?
|
| Receptors, Somatostatin | 1 | 2014 | 129 | 0.110 |
Why?
|
| Lovastatin | 1 | 1993 | 120 | 0.110 |
Why?
|
| Spine | 1 | 2020 | 1144 | 0.110 |
Why?
|
| Photography | 5 | 2020 | 520 | 0.110 |
Why?
|
| Adiponectin | 2 | 2018 | 1101 | 0.110 |
Why?
|
| Growth Differentiation Factors | 1 | 2014 | 98 | 0.110 |
Why?
|
| Rejuvenation | 1 | 2014 | 91 | 0.110 |
Why?
|
| Coronary Artery Disease | 7 | 2018 | 6486 | 0.110 |
Why?
|
| Glioma | 3 | 2019 | 3401 | 0.110 |
Why?
|
| Administration, Oral | 5 | 2018 | 3914 | 0.110 |
Why?
|
| Blindness | 2 | 2015 | 615 | 0.110 |
Why?
|
| 4-Butyrolactone | 1 | 2013 | 63 | 0.110 |
Why?
|
| Endophenotypes | 1 | 2015 | 250 | 0.110 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2016 | 555 | 0.110 |
Why?
|
| Neonatal Screening | 1 | 2017 | 591 | 0.110 |
Why?
|
| Physical Conditioning, Animal | 1 | 2016 | 354 | 0.110 |
Why?
|
| Mastocytosis, Systemic | 1 | 2014 | 100 | 0.110 |
Why?
|
| Urinary Catheterization | 3 | 1983 | 202 | 0.110 |
Why?
|
| Massachusetts | 16 | 2008 | 8662 | 0.110 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2003 | 550 | 0.110 |
Why?
|
| Digoxin | 1 | 2014 | 250 | 0.110 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 1372 | 0.110 |
Why?
|
| Epidemics | 1 | 2019 | 523 | 0.110 |
Why?
|
| DNA, Neoplasm | 3 | 2013 | 1758 | 0.110 |
Why?
|
| Complement C1 | 1 | 2012 | 33 | 0.110 |
Why?
|
| Infant, Premature | 3 | 2020 | 2045 | 0.110 |
Why?
|
| Ultraviolet Rays | 2 | 2020 | 1060 | 0.110 |
Why?
|
| Speech | 2 | 1990 | 541 | 0.110 |
Why?
|
| Contraceptives, Oral, Hormonal | 3 | 2007 | 188 | 0.110 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2015 | 472 | 0.110 |
Why?
|
| Lignans | 1 | 2013 | 81 | 0.110 |
Why?
|
| Normal Distribution | 1 | 1993 | 280 | 0.110 |
Why?
|
| Software | 2 | 2017 | 4441 | 0.110 |
Why?
|
| Progesterone | 1 | 2017 | 775 | 0.110 |
Why?
|
| Spinal Fractures | 1 | 2019 | 696 | 0.110 |
Why?
|
| Physicians | 5 | 2018 | 4567 | 0.110 |
Why?
|
| Sweetening Agents | 3 | 2021 | 296 | 0.110 |
Why?
|
| Pathology, Molecular | 1 | 2015 | 326 | 0.110 |
Why?
|
| Optic Atrophy | 1 | 2013 | 79 | 0.110 |
Why?
|
| Imidazoles | 3 | 2003 | 1206 | 0.110 |
Why?
|
| Poverty | 4 | 2019 | 2660 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2023 | 1462 | 0.110 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 1997 | 0.110 |
Why?
|
| Postpartum Period | 3 | 2019 | 1086 | 0.110 |
Why?
|
| Oral Health | 2 | 2016 | 474 | 0.110 |
Why?
|
| Gastroenteritis | 1 | 2014 | 245 | 0.110 |
Why?
|
| Tonometry, Ocular | 3 | 2019 | 237 | 0.110 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 658 | 0.110 |
Why?
|
| Fatigue | 2 | 2018 | 1531 | 0.110 |
Why?
|
| Fallopian Tubes | 1 | 2013 | 182 | 0.100 |
Why?
|
| Iodine | 1 | 2014 | 286 | 0.100 |
Why?
|
| Phenacetin | 7 | 1991 | 14 | 0.100 |
Why?
|
| Actigraphy | 1 | 2016 | 488 | 0.100 |
Why?
|
| Patients | 1 | 2019 | 900 | 0.100 |
Why?
|
| Attention | 5 | 2016 | 2397 | 0.100 |
Why?
|
| Herpesviridae Infections | 1 | 2013 | 277 | 0.100 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1378 | 0.100 |
Why?
|
| Absorptiometry, Photon | 2 | 2015 | 1725 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2022 | 2278 | 0.100 |
Why?
|
| Alopecia | 1 | 2016 | 382 | 0.100 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 1993 | 323 | 0.100 |
Why?
|
| Herpesvirus 8, Human | 1 | 2013 | 258 | 0.100 |
Why?
|
| Physical Examination | 1 | 2018 | 1237 | 0.100 |
Why?
|
| Models, Cardiovascular | 2 | 2001 | 996 | 0.100 |
Why?
|
| Radiography | 5 | 2018 | 7023 | 0.100 |
Why?
|
| DNA Methylation | 4 | 2018 | 4285 | 0.100 |
Why?
|
| Diabetes Mellitus | 7 | 2022 | 5749 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2020 | 2251 | 0.100 |
Why?
|
| Optical Devices | 1 | 2011 | 37 | 0.100 |
Why?
|
| Tooth Loss | 2 | 2003 | 197 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2013 | 3712 | 0.100 |
Why?
|
| Psychometrics | 1 | 2020 | 3003 | 0.100 |
Why?
|
| Community Health Centers | 2 | 2013 | 430 | 0.100 |
Why?
|
| Mathematical Computing | 4 | 2004 | 147 | 0.100 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 879 | 0.100 |
Why?
|
| Walking | 4 | 2024 | 1180 | 0.100 |
Why?
|
| Peptides, Cyclic | 1 | 2013 | 400 | 0.100 |
Why?
|
| Nuclear Family | 2 | 2008 | 318 | 0.100 |
Why?
|
| Optic Disk Drusen | 1 | 2011 | 35 | 0.100 |
Why?
|
| Survival Rate | 6 | 2023 | 12788 | 0.100 |
Why?
|
| Molecular Typing | 1 | 2011 | 106 | 0.100 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 361 | 0.100 |
Why?
|
| Anxiety | 3 | 2023 | 4293 | 0.100 |
Why?
|
| Blood Pressure Monitors | 1 | 1990 | 33 | 0.100 |
Why?
|
| Gene Frequency | 2 | 2018 | 3587 | 0.100 |
Why?
|
| Carcinoma, Basal Cell | 4 | 2020 | 545 | 0.100 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2010 | 39 | 0.100 |
Why?
|
| Social Support | 2 | 2019 | 2118 | 0.100 |
Why?
|
| Homosexuality, Female | 1 | 2012 | 156 | 0.090 |
Why?
|
| Sleep | 6 | 2024 | 4622 | 0.090 |
Why?
|
| California | 2 | 2013 | 1402 | 0.090 |
Why?
|
| Bisexuality | 1 | 2012 | 269 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 776 | 0.090 |
Why?
|
| Sunlight | 3 | 2002 | 325 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 1236 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 1968 | 0.090 |
Why?
|
| Respiration | 4 | 1995 | 1653 | 0.090 |
Why?
|
| Sodium | 6 | 2024 | 1622 | 0.090 |
Why?
|
| False Positive Reactions | 1 | 2013 | 980 | 0.090 |
Why?
|
| Benzhydryl Compounds | 1 | 2016 | 845 | 0.090 |
Why?
|
| Macular Edema | 1 | 2014 | 359 | 0.090 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2015 | 536 | 0.090 |
Why?
|
| Premature Birth | 1 | 2022 | 1721 | 0.090 |
Why?
|
| Brain Neoplasms | 4 | 2022 | 8861 | 0.090 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2013 | 324 | 0.090 |
Why?
|
| Disease | 1 | 2015 | 680 | 0.090 |
Why?
|
| C-Peptide | 1 | 2011 | 419 | 0.090 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 4933 | 0.090 |
Why?
|
| Developing Countries | 1 | 2022 | 2815 | 0.090 |
Why?
|
| Air Pollution | 1 | 2023 | 2286 | 0.090 |
Why?
|
| Family Characteristics | 4 | 2019 | 1000 | 0.090 |
Why?
|
| Aortic Valve | 1 | 2020 | 1924 | 0.090 |
Why?
|
| Lung | 12 | 2015 | 9857 | 0.090 |
Why?
|
| Folic Acid Deficiency | 1 | 2010 | 115 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 1888 | 0.090 |
Why?
|
| Behavior Control | 1 | 2009 | 45 | 0.090 |
Why?
|
| Physical Exertion | 5 | 2008 | 695 | 0.090 |
Why?
|
| Calcifediol | 1 | 2010 | 166 | 0.090 |
Why?
|
| Myopia | 1 | 2012 | 254 | 0.090 |
Why?
|
| Nevus | 3 | 2005 | 204 | 0.090 |
Why?
|
| Body Weights and Measures | 1 | 2010 | 211 | 0.090 |
Why?
|
| Precancerous Conditions | 2 | 2007 | 975 | 0.090 |
Why?
|
| Trace Elements | 3 | 1996 | 198 | 0.090 |
Why?
|
| Antigens, Viral | 1 | 2013 | 1035 | 0.090 |
Why?
|
| Genome, Bacterial | 1 | 2014 | 760 | 0.090 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 401 | 0.090 |
Why?
|
| Bariatric Surgery | 1 | 2019 | 952 | 0.090 |
Why?
|
| Complement Pathway, Alternative | 1 | 2009 | 126 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2020 | 1537 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2019 | 2926 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 2073 | 0.080 |
Why?
|
| Memory, Short-Term | 1 | 2015 | 977 | 0.080 |
Why?
|
| Neoplasm Staging | 7 | 2020 | 11031 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 2200 | 0.080 |
Why?
|
| Nails | 3 | 1996 | 292 | 0.080 |
Why?
|
| Neuropsychological Tests | 4 | 2016 | 6994 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2018 | 8949 | 0.080 |
Why?
|
| Glycemic Index | 3 | 2020 | 394 | 0.080 |
Why?
|
| Regeneration | 2 | 2016 | 1485 | 0.080 |
Why?
|
| Lighting | 1 | 2011 | 231 | 0.080 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2014 | 838 | 0.080 |
Why?
|
| Quality of Life | 3 | 2019 | 12802 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2020 | 3511 | 0.080 |
Why?
|
| Critical Illness | 2 | 2018 | 2670 | 0.080 |
Why?
|
| Reproductive Behavior | 1 | 2008 | 29 | 0.080 |
Why?
|
| Antibodies, Neoplasm | 1 | 2010 | 286 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 216 | 0.080 |
Why?
|
| Bronchial Hyperreactivity | 3 | 1995 | 319 | 0.080 |
Why?
|
| Mongolia | 2 | 2018 | 91 | 0.080 |
Why?
|
| Bronchial Provocation Tests | 6 | 1995 | 227 | 0.080 |
Why?
|
| Behavior | 2 | 2011 | 561 | 0.080 |
Why?
|
| Anticonvulsants | 1 | 2018 | 1916 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2011 | 390 | 0.080 |
Why?
|
| Emergency Medicine | 1 | 2018 | 1205 | 0.080 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2008 | 86 | 0.080 |
Why?
|
| Plasmids | 1 | 2013 | 2308 | 0.080 |
Why?
|
| Streptococcus agalactiae | 4 | 1998 | 375 | 0.080 |
Why?
|
| Talc | 1 | 2008 | 47 | 0.080 |
Why?
|
| Abdomen | 5 | 2005 | 1118 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 560 | 0.080 |
Why?
|
| Valproic Acid | 1 | 2010 | 445 | 0.080 |
Why?
|
| HLA Antigens | 1 | 2013 | 1382 | 0.080 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2011 | 378 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2016 | 2499 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2020 | 4034 | 0.080 |
Why?
|
| Bronchitis | 7 | 1998 | 200 | 0.080 |
Why?
|
| Contrast Sensitivity | 3 | 1993 | 244 | 0.080 |
Why?
|
| Dihydroxycholecalciferols | 1 | 2007 | 17 | 0.080 |
Why?
|
| Syndrome | 4 | 2015 | 3252 | 0.080 |
Why?
|
| Adolescent Development | 1 | 2011 | 279 | 0.080 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2009 | 338 | 0.080 |
Why?
|
| Apolipoproteins E | 2 | 2012 | 1438 | 0.070 |
Why?
|
| Dermatology | 1 | 2017 | 872 | 0.070 |
Why?
|
| Human Growth Hormone | 1 | 2012 | 683 | 0.070 |
Why?
|
| Genes, Recessive | 4 | 2008 | 641 | 0.070 |
Why?
|
| Comorbidity | 6 | 2019 | 10388 | 0.070 |
Why?
|
| Mast Cells | 1 | 2014 | 1544 | 0.070 |
Why?
|
| Echocardiography | 4 | 2021 | 5099 | 0.070 |
Why?
|
| Energy Metabolism | 4 | 2015 | 2897 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 2212 | 0.070 |
Why?
|
| Brain Ischemia | 3 | 2019 | 3265 | 0.070 |
Why?
|
| Data Collection | 2 | 2023 | 3339 | 0.070 |
Why?
|
| Epitopes | 1 | 2013 | 2571 | 0.070 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 950 | 0.070 |
Why?
|
| Immunohistochemistry | 5 | 2023 | 11366 | 0.070 |
Why?
|
| Diterpenes | 3 | 2018 | 173 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2013 | 1532 | 0.070 |
Why?
|
| Public Health | 2 | 2018 | 2602 | 0.070 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2007 | 129 | 0.070 |
Why?
|
| Lipoproteins | 5 | 1996 | 878 | 0.070 |
Why?
|
| Anthocyanins | 2 | 2020 | 79 | 0.070 |
Why?
|
| DNA Replication | 1 | 2013 | 1399 | 0.070 |
Why?
|
| Maternal Exposure | 2 | 2017 | 961 | 0.070 |
Why?
|
| Sexual Behavior | 8 | 2014 | 2055 | 0.070 |
Why?
|
| Databases, Factual | 4 | 2020 | 7730 | 0.070 |
Why?
|
| Genital Diseases, Female | 4 | 2019 | 197 | 0.070 |
Why?
|
| Molecular Epidemiology | 1 | 2008 | 468 | 0.070 |
Why?
|
| Population Dynamics | 1 | 2008 | 302 | 0.070 |
Why?
|
| Zinc | 3 | 2008 | 684 | 0.070 |
Why?
|
| Needlestick Injuries | 1 | 2006 | 67 | 0.070 |
Why?
|
| Vulnerable Populations | 1 | 2012 | 686 | 0.070 |
Why?
|
| Glutathione Transferase | 1 | 2008 | 595 | 0.070 |
Why?
|
| Pregnancy Outcome | 3 | 2022 | 2795 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 2400 | 0.070 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 1788 | 0.070 |
Why?
|
| Vital Capacity | 10 | 2002 | 925 | 0.070 |
Why?
|
| Exudates and Transudates | 1 | 2006 | 172 | 0.070 |
Why?
|
| Genome-Wide Association Study | 4 | 2019 | 12262 | 0.070 |
Why?
|
| Fatty Acids, Unsaturated | 5 | 2009 | 546 | 0.070 |
Why?
|
| Caregivers | 1 | 2018 | 2095 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 1837 | 0.070 |
Why?
|
| Flavones | 2 | 2020 | 66 | 0.070 |
Why?
|
| Diet, Atherogenic | 1 | 2005 | 95 | 0.070 |
Why?
|
| Learning | 1 | 2015 | 1711 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 2865 | 0.070 |
Why?
|
| Dark Adaptation | 4 | 2003 | 219 | 0.070 |
Why?
|
| Fishes | 3 | 2009 | 569 | 0.070 |
Why?
|
| Ocular Hypertension | 1 | 1987 | 198 | 0.070 |
Why?
|
| Trans-Activators | 1 | 2016 | 2926 | 0.070 |
Why?
|
| Leukoplakia, Oral | 1 | 2006 | 73 | 0.070 |
Why?
|
| Introns | 1 | 2008 | 992 | 0.070 |
Why?
|
| Methacholine Chloride | 4 | 1994 | 233 | 0.070 |
Why?
|
| Substance-Related Disorders | 4 | 2017 | 4257 | 0.070 |
Why?
|
| Cell Division | 5 | 1985 | 4569 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3707 | 0.070 |
Why?
|
| Epigenomics | 1 | 2011 | 903 | 0.070 |
Why?
|
| Lymphoma | 1 | 2014 | 1877 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 2038 | 0.070 |
Why?
|
| Androgens | 2 | 2010 | 1281 | 0.070 |
Why?
|
| Skin | 2 | 2015 | 4372 | 0.070 |
Why?
|
| Leucine | 2 | 2021 | 560 | 0.070 |
Why?
|
| Mucin-1 | 1 | 2010 | 543 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3611 | 0.070 |
Why?
|
| Mathematics | 3 | 2015 | 728 | 0.070 |
Why?
|
| Controlled Clinical Trials as Topic | 2 | 2003 | 187 | 0.060 |
Why?
|
| Intelligence | 1 | 1990 | 920 | 0.060 |
Why?
|
| Naphazoline | 1 | 1984 | 7 | 0.060 |
Why?
|
| Vitamin D-Binding Protein | 2 | 2018 | 129 | 0.060 |
Why?
|
| Autoantibodies | 1 | 2013 | 2036 | 0.060 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 3057 | 0.060 |
Why?
|
| Fibrinopeptide A | 1 | 2004 | 44 | 0.060 |
Why?
|
| Calcium Channel Blockers | 2 | 1998 | 692 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2011 | 1340 | 0.060 |
Why?
|
| Respiratory Function Tests | 5 | 2015 | 1617 | 0.060 |
Why?
|
| Nursing | 1 | 2004 | 40 | 0.060 |
Why?
|
| Renin | 2 | 2024 | 642 | 0.060 |
Why?
|
| Lacerations | 1 | 2006 | 144 | 0.060 |
Why?
|
| Japan | 2 | 2022 | 1360 | 0.060 |
Why?
|
| Estriol | 1 | 1984 | 53 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3395 | 0.060 |
Why?
|
| Patient Selection | 3 | 2013 | 4216 | 0.060 |
Why?
|
| Accidents, Occupational | 1 | 2006 | 251 | 0.060 |
Why?
|
| Plasmalogens | 2 | 2022 | 30 | 0.060 |
Why?
|
| Food Services | 1 | 2008 | 192 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2019 | 8432 | 0.060 |
Why?
|
| Diet, Reducing | 2 | 2009 | 462 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2014 | 5974 | 0.060 |
Why?
|
| Creatinine | 8 | 2022 | 1919 | 0.060 |
Why?
|
| Memory | 4 | 2016 | 2174 | 0.060 |
Why?
|
| Educational Status | 3 | 1999 | 2540 | 0.060 |
Why?
|
| Receptors, Glucocorticoid | 3 | 1981 | 302 | 0.060 |
Why?
|
| Glucose Tolerance Test | 2 | 2021 | 1151 | 0.060 |
Why?
|
| Camping | 1 | 2003 | 13 | 0.060 |
Why?
|
| Prothrombin | 1 | 2004 | 185 | 0.060 |
Why?
|
| Photic Stimulation | 2 | 2018 | 2026 | 0.060 |
Why?
|
| Random Allocation | 10 | 2013 | 2428 | 0.060 |
Why?
|
| Dinoprost | 1 | 2004 | 138 | 0.060 |
Why?
|
| Histamine | 3 | 1995 | 507 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 850 | 0.060 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 2494 | 0.060 |
Why?
|
| Macrophages | 1 | 2018 | 5660 | 0.060 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2006 | 222 | 0.060 |
Why?
|
| Respiratory Sounds | 3 | 1993 | 696 | 0.060 |
Why?
|
| Wound Healing | 1 | 2015 | 2785 | 0.060 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 2023 | 36 | 0.060 |
Why?
|
| Ozone | 2 | 1998 | 469 | 0.060 |
Why?
|
| Pain | 1 | 2019 | 4988 | 0.060 |
Why?
|
| Photoreceptor Cells | 3 | 1998 | 244 | 0.060 |
Why?
|
| Animals | 23 | 2024 | 168768 | 0.060 |
Why?
|
| Patient Participation | 1 | 2013 | 1457 | 0.060 |
Why?
|
| Antigens, Surface | 2 | 1998 | 1663 | 0.060 |
Why?
|
| Pruritus | 1 | 2006 | 361 | 0.060 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 5856 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2014 | 2638 | 0.060 |
Why?
|
| Ophthalmic Solutions | 1 | 1984 | 317 | 0.060 |
Why?
|
| Receptors, Leptin | 2 | 2018 | 361 | 0.060 |
Why?
|
| Drug Therapy, Combination | 8 | 2010 | 6489 | 0.060 |
Why?
|
| Self Concept | 2 | 2007 | 1025 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2022 | 1695 | 0.060 |
Why?
|
| Aldehyde Reductase | 2 | 2000 | 65 | 0.060 |
Why?
|
| Contraception | 3 | 2021 | 359 | 0.060 |
Why?
|
| Language Development | 1 | 1984 | 187 | 0.060 |
Why?
|
| Disposable Equipment | 1 | 2022 | 43 | 0.060 |
Why?
|
| Leptin | 1 | 2011 | 1600 | 0.060 |
Why?
|
| Saliva | 2 | 2019 | 809 | 0.060 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2007 | 372 | 0.060 |
Why?
|
| Central Nervous System Stimulants | 1 | 2011 | 1148 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2011 | 3047 | 0.050 |
Why?
|
| Sucking Behavior | 1 | 2002 | 28 | 0.050 |
Why?
|
| Fragile X Syndrome | 1 | 2004 | 115 | 0.050 |
Why?
|
| Receptor, Insulin | 2 | 2018 | 847 | 0.050 |
Why?
|
| Parents | 4 | 2010 | 3405 | 0.050 |
Why?
|
| Adolescent Behavior | 1 | 2011 | 1151 | 0.050 |
Why?
|
| Inflammation | 2 | 2021 | 10637 | 0.050 |
Why?
|
| Epilepsy | 1 | 2018 | 3310 | 0.050 |
Why?
|
| Tamoxifen | 1 | 2007 | 981 | 0.050 |
Why?
|
| Exons | 1 | 2008 | 2439 | 0.050 |
Why?
|
| Acute Disease | 5 | 2023 | 7147 | 0.050 |
Why?
|
| Receptors, Calcitriol | 2 | 2016 | 348 | 0.050 |
Why?
|
| Lysophosphatidylcholines | 1 | 2022 | 81 | 0.050 |
Why?
|
| Postoperative Complications | 4 | 2023 | 15297 | 0.050 |
Why?
|
| Brazil | 2 | 2018 | 1270 | 0.050 |
Why?
|
| Norgestrel | 1 | 2021 | 11 | 0.050 |
Why?
|
| Retinal Detachment | 1 | 2006 | 411 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2004 | 464 | 0.050 |
Why?
|
| Desogestrel | 1 | 2021 | 23 | 0.050 |
Why?
|
| Lung Volume Measurements | 2 | 1980 | 378 | 0.050 |
Why?
|
| Ocular Physiological Phenomena | 1 | 1982 | 70 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7882 | 0.050 |
Why?
|
| Follicular Atresia | 1 | 2021 | 8 | 0.050 |
Why?
|
| Thrombin | 1 | 2004 | 598 | 0.050 |
Why?
|
| Choice Behavior | 1 | 2008 | 802 | 0.050 |
Why?
|
| Medical Records | 5 | 2003 | 1413 | 0.050 |
Why?
|
| Ion Channel Gating | 1 | 2004 | 437 | 0.050 |
Why?
|
| Melanoma | 5 | 2005 | 5511 | 0.050 |
Why?
|
| Sensory Thresholds | 1 | 2003 | 391 | 0.050 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2024 | 281 | 0.050 |
Why?
|
| Recurrence | 7 | 2004 | 8340 | 0.050 |
Why?
|
| Cholesterol, Dietary | 5 | 2003 | 231 | 0.050 |
Why?
|
| Bone Resorption | 2 | 2002 | 723 | 0.050 |
Why?
|
| Psychology | 2 | 2018 | 356 | 0.050 |
Why?
|
| Isoleucine | 1 | 2021 | 112 | 0.050 |
Why?
|
| Internship and Residency | 3 | 2006 | 5791 | 0.050 |
Why?
|
| Levonorgestrel | 1 | 2021 | 77 | 0.050 |
Why?
|
| Biological Clocks | 1 | 2024 | 322 | 0.050 |
Why?
|
| Child Development | 2 | 2011 | 2223 | 0.050 |
Why?
|
| Sulfisoxazole | 1 | 2000 | 8 | 0.050 |
Why?
|
| Urban Population | 3 | 2019 | 2022 | 0.050 |
Why?
|
| Child Behavior Disorders | 2 | 2004 | 807 | 0.050 |
Why?
|
| Antihypertensive Agents | 2 | 1991 | 2047 | 0.050 |
Why?
|
| Blood Proteins | 2 | 1995 | 1124 | 0.050 |
Why?
|
| Ethinyl Estradiol | 1 | 2021 | 116 | 0.050 |
Why?
|
| Bronchi | 3 | 2011 | 840 | 0.050 |
Why?
|
| Vasoconstrictor Agents | 1 | 1984 | 642 | 0.050 |
Why?
|
| Health Education | 1 | 2008 | 1056 | 0.050 |
Why?
|
| Mycoplasma Infections | 6 | 1987 | 118 | 0.050 |
Why?
|
| Language | 1 | 1990 | 1471 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2004 | 366 | 0.050 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2021 | 113 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 10 | 1988 | 7182 | 0.050 |
Why?
|
| Germany | 2 | 2014 | 862 | 0.050 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 604 | 0.050 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2004 | 544 | 0.050 |
Why?
|
| Leisure Activities | 3 | 2015 | 311 | 0.050 |
Why?
|
| Recreation | 1 | 2001 | 115 | 0.050 |
Why?
|
| Paternal Age | 3 | 2006 | 84 | 0.050 |
Why?
|
| HSP110 Heat-Shock Proteins | 1 | 2020 | 10 | 0.050 |
Why?
|
| Insulin | 3 | 2020 | 6582 | 0.050 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2020 | 34 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3771 | 0.050 |
Why?
|
| Neural Conduction | 1 | 2002 | 440 | 0.050 |
Why?
|
| Receptors, Steroid | 1 | 1981 | 155 | 0.050 |
Why?
|
| Food, Organic | 2 | 2012 | 34 | 0.050 |
Why?
|
| Arteriosclerosis | 2 | 2003 | 1092 | 0.050 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2000 | 46 | 0.050 |
Why?
|
| Infertility | 1 | 2007 | 655 | 0.050 |
Why?
|
| Immunoassay | 2 | 2014 | 752 | 0.050 |
Why?
|
| Flavonols | 1 | 2020 | 83 | 0.050 |
Why?
|
| Chewing Gum | 1 | 2000 | 41 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2023 | 690 | 0.050 |
Why?
|
| Bacteriuria | 6 | 1983 | 102 | 0.050 |
Why?
|
| Students | 2 | 2008 | 1647 | 0.040 |
Why?
|
| Administration, Inhalation | 2 | 2015 | 1105 | 0.040 |
Why?
|
| Retinal Diseases | 2 | 2003 | 684 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2004 | 950 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 2004 | 602 | 0.040 |
Why?
|
| China | 3 | 2015 | 2245 | 0.040 |
Why?
|
| Erythrocytes | 3 | 2020 | 2455 | 0.040 |
Why?
|
| Dexamethasone | 4 | 1985 | 1951 | 0.040 |
Why?
|
| Amoxicillin | 1 | 2000 | 170 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 2 | 2017 | 680 | 0.040 |
Why?
|
| Habits | 1 | 2020 | 139 | 0.040 |
Why?
|
| Form Perception | 1 | 2001 | 182 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 5 | 2008 | 5388 | 0.040 |
Why?
|
| Psychological Tests | 2 | 1999 | 651 | 0.040 |
Why?
|
| alpha-Amylases | 1 | 2019 | 41 | 0.040 |
Why?
|
| Selenium | 3 | 1995 | 405 | 0.040 |
Why?
|
| Albumins | 1 | 2022 | 568 | 0.040 |
Why?
|
| Haplotypes | 3 | 2011 | 2779 | 0.040 |
Why?
|
| Asbestosis | 1 | 1979 | 82 | 0.040 |
Why?
|
| Periodontal Diseases | 1 | 2003 | 449 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2000 | 513 | 0.040 |
Why?
|
| Cathartics | 1 | 2000 | 125 | 0.040 |
Why?
|
| Genetics, Behavioral | 1 | 1999 | 53 | 0.040 |
Why?
|
| Proline | 2 | 1991 | 458 | 0.040 |
Why?
|
| Accidents, Traffic | 1 | 2005 | 819 | 0.040 |
Why?
|
| Genomics | 1 | 2015 | 5717 | 0.040 |
Why?
|
| Perceptual Disorders | 1 | 2001 | 196 | 0.040 |
Why?
|
| Steroids | 1 | 2004 | 930 | 0.040 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2004 | 615 | 0.040 |
Why?
|
| Time | 1 | 2020 | 542 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2002 | 1590 | 0.040 |
Why?
|
| Dogs | 1 | 2024 | 3912 | 0.040 |
Why?
|
| Asia | 1 | 2020 | 609 | 0.040 |
Why?
|
| Office Visits | 2 | 2015 | 598 | 0.040 |
Why?
|
| Intergenerational Relations | 1 | 2019 | 68 | 0.040 |
Why?
|
| Cell Survival | 2 | 1979 | 5882 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4925 | 0.040 |
Why?
|
| Defecation | 1 | 2000 | 188 | 0.040 |
Why?
|
| Workload | 1 | 2005 | 849 | 0.040 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2019 | 143 | 0.040 |
Why?
|
| Glutathione Peroxidase | 1 | 2000 | 255 | 0.040 |
Why?
|
| Mother-Child Relations | 1 | 1982 | 481 | 0.040 |
Why?
|
| Heart Failure | 2 | 2022 | 10895 | 0.040 |
Why?
|
| Biopsy | 3 | 2019 | 6755 | 0.040 |
Why?
|
| Sweden | 2 | 2018 | 1341 | 0.040 |
Why?
|
| Mycoplasma | 5 | 1986 | 139 | 0.040 |
Why?
|
| Riboflavin | 2 | 2016 | 108 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 890 | 0.040 |
Why?
|
| Administration, Cutaneous | 2 | 2018 | 711 | 0.040 |
Why?
|
| Stroke Volume | 2 | 2022 | 5006 | 0.040 |
Why?
|
| Low Tension Glaucoma | 1 | 2018 | 22 | 0.040 |
Why?
|
| Pilot Projects | 4 | 2020 | 8319 | 0.040 |
Why?
|
| Snoring | 1 | 1999 | 191 | 0.040 |
Why?
|
| Netherlands | 3 | 2009 | 2170 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2011 | 5023 | 0.040 |
Why?
|
| Iron | 1 | 2006 | 1774 | 0.040 |
Why?
|
| Traction | 1 | 2018 | 106 | 0.040 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2015 | 415 | 0.040 |
Why?
|
| Medical History Taking | 4 | 1998 | 784 | 0.040 |
Why?
|
| Medical Errors | 1 | 2006 | 1297 | 0.040 |
Why?
|
| Personality | 1 | 2002 | 552 | 0.040 |
Why?
|
| Puerto Rico | 2 | 2010 | 356 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2022 | 3749 | 0.040 |
Why?
|
| Trichomonas vaginalis | 2 | 2017 | 76 | 0.040 |
Why?
|
| Bangladesh | 1 | 2020 | 687 | 0.040 |
Why?
|
| Air Pollutants, Occupational | 2 | 1985 | 408 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2023 | 711 | 0.040 |
Why?
|
| Light | 1 | 2004 | 1374 | 0.040 |
Why?
|
| Arteries | 1 | 2003 | 1119 | 0.040 |
Why?
|
| Receptors, Adiponectin | 1 | 2018 | 82 | 0.040 |
Why?
|
| Voice Quality | 1 | 2019 | 217 | 0.040 |
Why?
|
| Nursing Staff | 2 | 2015 | 129 | 0.040 |
Why?
|
| Oxidants, Photochemical | 1 | 1998 | 78 | 0.040 |
Why?
|
| Respiratory Mechanics | 1 | 2002 | 686 | 0.040 |
Why?
|
| Menstruation | 4 | 2005 | 302 | 0.040 |
Why?
|
| Financial Management | 1 | 2019 | 160 | 0.040 |
Why?
|
| Primary Health Care | 2 | 2012 | 4557 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2020 | 407 | 0.040 |
Why?
|
| Anticholesteremic Agents | 2 | 1995 | 979 | 0.040 |
Why?
|
| Ureaplasma | 5 | 1987 | 59 | 0.040 |
Why?
|
| Heart Diseases | 2 | 2015 | 2789 | 0.040 |
Why?
|
| Food Analysis | 2 | 1990 | 104 | 0.040 |
Why?
|
| Residence Characteristics | 2 | 2007 | 2050 | 0.040 |
Why?
|
| Menstruation Disturbances | 1 | 2018 | 148 | 0.040 |
Why?
|
| Asbestos | 1 | 1979 | 251 | 0.040 |
Why?
|
| Hypnosis | 1 | 1978 | 82 | 0.040 |
Why?
|
| Luteal Phase | 1 | 2018 | 147 | 0.040 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 2013 | 507 | 0.040 |
Why?
|
| Space Perception | 1 | 2001 | 475 | 0.040 |
Why?
|
| Follicular Phase | 1 | 2018 | 153 | 0.040 |
Why?
|
| Mutation | 6 | 2013 | 29786 | 0.040 |
Why?
|
| Climate | 1 | 2018 | 147 | 0.040 |
Why?
|
| Methylnitrosourea | 1 | 2016 | 29 | 0.040 |
Why?
|
| Sodium Salicylate | 1 | 2016 | 19 | 0.040 |
Why?
|
| Collagen Type V | 1 | 2016 | 16 | 0.040 |
Why?
|
| Leukemia, Lymphoid | 1 | 2017 | 315 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2020 | 881 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2000 | 596 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2016 | 50 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2019 | 481 | 0.040 |
Why?
|
| Lead | 1 | 2002 | 852 | 0.040 |
Why?
|
| Warfarin | 3 | 2004 | 1497 | 0.040 |
Why?
|
| Kidney Diseases | 8 | 1991 | 2148 | 0.040 |
Why?
|
| Program Evaluation | 3 | 2014 | 2488 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2008 | 3508 | 0.040 |
Why?
|
| Retinoid X Receptors | 1 | 2016 | 93 | 0.040 |
Why?
|
| Enalapril | 1 | 2018 | 327 | 0.040 |
Why?
|
| Internet | 2 | 2019 | 3056 | 0.040 |
Why?
|
| Drug Evaluation | 2 | 1991 | 647 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 1142 | 0.040 |
Why?
|
| Relaxation Therapy | 1 | 1978 | 178 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2020 | 9445 | 0.040 |
Why?
|
| Dermatoglyphics | 1 | 1976 | 21 | 0.040 |
Why?
|
| Dipeptides | 1 | 2019 | 409 | 0.040 |
Why?
|
| Fertility | 2 | 1997 | 781 | 0.040 |
Why?
|
| Phlebotomy | 1 | 2017 | 141 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2004 | 2166 | 0.040 |
Why?
|
| Oxidative Stress | 2 | 2015 | 3084 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2011 | 3079 | 0.040 |
Why?
|
| Sunburn | 3 | 2005 | 155 | 0.030 |
Why?
|
| Rotation | 1 | 2018 | 523 | 0.030 |
Why?
|
| Epithelium | 1 | 2021 | 1679 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1998 | 798 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 2016 | 139 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 1984 | 1453 | 0.030 |
Why?
|
| Automation, Laboratory | 1 | 2016 | 101 | 0.030 |
Why?
|
| Carcinoma | 1 | 2008 | 2375 | 0.030 |
Why?
|
| Antibodies, Protozoan | 1 | 2017 | 253 | 0.030 |
Why?
|
| Pedigree | 4 | 2019 | 4642 | 0.030 |
Why?
|
| State Medicine | 1 | 2017 | 217 | 0.030 |
Why?
|
| Hospitals, General | 5 | 1979 | 749 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2017 | 223 | 0.030 |
Why?
|
| Point Mutation | 2 | 1998 | 1624 | 0.030 |
Why?
|
| Geography | 1 | 2018 | 669 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 2016 | 919 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2015 | 9240 | 0.030 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1996 | 134 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2020 | 693 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2021 | 1355 | 0.030 |
Why?
|
| Thymine | 1 | 2015 | 68 | 0.030 |
Why?
|
| Spain | 1 | 2017 | 465 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2016 | 336 | 0.030 |
Why?
|
| Sulfates | 1 | 2016 | 390 | 0.030 |
Why?
|
| Genistein | 1 | 2015 | 88 | 0.030 |
Why?
|
| Women's Health Services | 1 | 2016 | 93 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2000 | 639 | 0.030 |
Why?
|
| Mexico | 1 | 2017 | 689 | 0.030 |
Why?
|
| Vagina | 5 | 1986 | 825 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2000 | 632 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2019 | 23404 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2010 | 1572 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 6539 | 0.030 |
Why?
|
| Causality | 1 | 2022 | 1275 | 0.030 |
Why?
|
| Genetic Markers | 2 | 2012 | 2634 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2020 | 986 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 2 | 2014 | 1677 | 0.030 |
Why?
|
| Thiamine | 1 | 2016 | 152 | 0.030 |
Why?
|
| Streptococcal Infections | 2 | 1998 | 638 | 0.030 |
Why?
|
| Dementia | 1 | 2009 | 2518 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 5 | 2004 | 850 | 0.030 |
Why?
|
| Nicotine | 1 | 2000 | 681 | 0.030 |
Why?
|
| Diabetes Complications | 7 | 1999 | 1359 | 0.030 |
Why?
|
| Coma | 1 | 2018 | 475 | 0.030 |
Why?
|
| Feces | 1 | 2001 | 1401 | 0.030 |
Why?
|
| Muscle Development | 1 | 2016 | 271 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 1423 | 0.030 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2014 | 143 | 0.030 |
Why?
|
| Cotinine | 1 | 1995 | 206 | 0.030 |
Why?
|
| Bacterial Proteins | 2 | 1998 | 3854 | 0.030 |
Why?
|
| Fractures, Bone | 3 | 2019 | 1947 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2015 | 344 | 0.030 |
Why?
|
| Parabiosis | 1 | 2014 | 65 | 0.030 |
Why?
|
| Videodisc Recording | 1 | 2013 | 14 | 0.030 |
Why?
|
| Cytosine | 1 | 2015 | 216 | 0.030 |
Why?
|
| Pediatrics | 1 | 2009 | 3475 | 0.030 |
Why?
|
| Food Handling | 1 | 2014 | 145 | 0.030 |
Why?
|
| Attitude to Health | 4 | 2008 | 2052 | 0.030 |
Why?
|
| Drug Utilization | 6 | 1996 | 1183 | 0.030 |
Why?
|
| Infant Formula | 1 | 2015 | 199 | 0.030 |
Why?
|
| Bacteroides Infections | 1 | 1993 | 82 | 0.030 |
Why?
|
| Lost to Follow-Up | 1 | 2014 | 105 | 0.030 |
Why?
|
| Binomial Distribution | 1 | 1993 | 25 | 0.030 |
Why?
|
| Fasting | 3 | 2014 | 1592 | 0.030 |
Why?
|
| Nifedipine | 2 | 1984 | 227 | 0.030 |
Why?
|
| Placebos | 3 | 1994 | 1676 | 0.030 |
Why?
|
| Nephritis, Hereditary | 1 | 1974 | 88 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2015 | 230 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3799 | 0.030 |
Why?
|
| Margarine | 1 | 1993 | 17 | 0.030 |
Why?
|
| Laboratories | 1 | 2017 | 463 | 0.030 |
Why?
|
| Coronary Angiography | 6 | 1995 | 4576 | 0.030 |
Why?
|
| Meningitis, Meningococcal | 1 | 1973 | 43 | 0.030 |
Why?
|
| Empirical Research | 1 | 2013 | 120 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2019 | 861 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13693 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 346 | 0.030 |
Why?
|
| Colorimetry | 1 | 1993 | 147 | 0.030 |
Why?
|
| Placental Hormones | 1 | 2012 | 14 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2019 | 1534 | 0.030 |
Why?
|
| Mosaicism | 1 | 1976 | 441 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 1980 | 961 | 0.030 |
Why?
|
| Consciousness Disorders | 1 | 1997 | 418 | 0.030 |
Why?
|
| Phosphates | 1 | 2016 | 785 | 0.030 |
Why?
|
| Mental Disorders | 2 | 2010 | 6598 | 0.030 |
Why?
|
| Atherectomy, Coronary | 1 | 1993 | 148 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2010 | 2539 | 0.030 |
Why?
|
| Cross-Over Studies | 3 | 2005 | 2029 | 0.030 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2013 | 61 | 0.030 |
Why?
|
| Bacteroides fragilis | 1 | 1993 | 212 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.030 |
Why?
|
| Visual Field Tests | 2 | 2010 | 383 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2018 | 1572 | 0.030 |
Why?
|
| Pyrus | 1 | 2012 | 12 | 0.030 |
Why?
|
| Bacterial Capsules | 1 | 1993 | 251 | 0.030 |
Why?
|
| Epoxy Compounds | 1 | 2013 | 136 | 0.030 |
Why?
|
| Program Development | 1 | 2019 | 1316 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1994 | 392 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2014 | 538 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2016 | 471 | 0.030 |
Why?
|
| Ohio | 2 | 2009 | 337 | 0.030 |
Why?
|
| Sp3 Transcription Factor | 1 | 2011 | 29 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2019 | 1828 | 0.030 |
Why?
|
| Sports | 1 | 1998 | 688 | 0.030 |
Why?
|
| Apolipoprotein A-II | 1 | 1992 | 39 | 0.030 |
Why?
|
| Videotape Recording | 1 | 2013 | 352 | 0.030 |
Why?
|
| Visual Perception | 1 | 2001 | 1420 | 0.030 |
Why?
|
| Observer Variation | 1 | 2018 | 2593 | 0.030 |
Why?
|
| Keratin-6 | 1 | 2011 | 18 | 0.030 |
Why?
|
| Phthalic Acids | 1 | 2016 | 436 | 0.030 |
Why?
|
| Particulate Matter | 1 | 2023 | 2529 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2011 | 19233 | 0.030 |
Why?
|
| Spirometry | 6 | 1998 | 865 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 624 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2004 | 5096 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 2 | 2011 | 3616 | 0.030 |
Why?
|
| Keratin-5 | 1 | 2011 | 46 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1799 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2013 | 288 | 0.030 |
Why?
|
| Malus | 1 | 2012 | 48 | 0.030 |
Why?
|
| Weather | 1 | 2013 | 228 | 0.030 |
Why?
|
| DNA Damage | 1 | 2001 | 2432 | 0.030 |
Why?
|
| Molecular Sequence Data | 5 | 2013 | 18111 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2003 | 2873 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2011 | 300 | 0.020 |
Why?
|
| Forearm Injuries | 1 | 1991 | 67 | 0.020 |
Why?
|
| Choline | 1 | 2013 | 493 | 0.020 |
Why?
|
| New England | 2 | 2013 | 1022 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2013 | 876 | 0.020 |
Why?
|
| New Hampshire | 2 | 2008 | 172 | 0.020 |
Why?
|
| Telephone | 2 | 2012 | 617 | 0.020 |
Why?
|
| Cell Line | 5 | 2013 | 16000 | 0.020 |
Why?
|
| Ultrasonography | 3 | 2019 | 5984 | 0.020 |
Why?
|
| Carbon Dioxide | 3 | 2006 | 1150 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 2 | 2013 | 1342 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 1195 | 0.020 |
Why?
|
| Urine | 4 | 1983 | 370 | 0.020 |
Why?
|
| Length of Stay | 3 | 2020 | 6311 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3590 | 0.020 |
Why?
|
| Selection Bias | 2 | 2008 | 371 | 0.020 |
Why?
|
| Functional Residual Capacity | 1 | 2010 | 68 | 0.020 |
Why?
|
| Posture | 2 | 1986 | 958 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2011 | 374 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 1793 | 0.020 |
Why?
|
| Apolipoprotein A-I | 1 | 1992 | 281 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2017 | 931 | 0.020 |
Why?
|
| Eligibility Determination | 1 | 1994 | 403 | 0.020 |
Why?
|
| Bronchoconstriction | 1 | 1991 | 143 | 0.020 |
Why?
|
| Kallikreins | 4 | 1987 | 258 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2019 | 812 | 0.020 |
Why?
|
| Women | 1 | 2012 | 230 | 0.020 |
Why?
|
| Electric Stimulation Therapy | 1 | 1996 | 605 | 0.020 |
Why?
|
| Occupations | 1 | 1992 | 517 | 0.020 |
Why?
|
| Cold Temperature | 3 | 1989 | 772 | 0.020 |
Why?
|
| Cystadenocarcinoma | 1 | 2009 | 55 | 0.020 |
Why?
|
| Histidine | 1 | 1991 | 313 | 0.020 |
Why?
|
| Reaction Time | 1 | 2016 | 2098 | 0.020 |
Why?
|
| Complement Factor I | 1 | 2009 | 14 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2016 | 1915 | 0.020 |
Why?
|
| Microsatellite Instability | 1 | 2013 | 684 | 0.020 |
Why?
|
| Beer | 4 | 1993 | 127 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 1998 | 1456 | 0.020 |
Why?
|
| Toes | 3 | 1996 | 206 | 0.020 |
Why?
|
| Models, Econometric | 1 | 2010 | 218 | 0.020 |
Why?
|
| Proteomics | 1 | 2023 | 3638 | 0.020 |
Why?
|
| Abscess | 1 | 1993 | 607 | 0.020 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1999 | 1444 | 0.020 |
Why?
|
| Contrast Media | 1 | 2023 | 5300 | 0.020 |
Why?
|
| Tablets | 1 | 2010 | 145 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2014 | 1880 | 0.020 |
Why?
|
| Congenital Abnormalities | 3 | 1985 | 707 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 3666 | 0.020 |
Why?
|
| Running | 2 | 2008 | 480 | 0.020 |
Why?
|
| Apigenin | 1 | 2009 | 14 | 0.020 |
Why?
|
| Platelet Activation | 1 | 1993 | 674 | 0.020 |
Why?
|
| Outpatients | 1 | 2017 | 1487 | 0.020 |
Why?
|
| Child Nutrition Sciences | 1 | 2009 | 23 | 0.020 |
Why?
|
| Budesonide | 1 | 2010 | 154 | 0.020 |
Why?
|
| Information Systems | 1 | 2011 | 410 | 0.020 |
Why?
|
| Bottle Feeding | 1 | 1989 | 66 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 1831 | 0.020 |
Why?
|
| Preventive Health Services | 1 | 2014 | 575 | 0.020 |
Why?
|
| Organ Size | 1 | 2014 | 2251 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2013 | 367 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 780 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1989 | 220 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1995 | 2560 | 0.020 |
Why?
|
| Erythromycin | 2 | 1987 | 120 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5077 | 0.020 |
Why?
|
| Commerce | 1 | 2014 | 592 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2013 | 13814 | 0.020 |
Why?
|
| Codon | 1 | 1991 | 611 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 1637 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 894 | 0.020 |
Why?
|
| Chlamydia Infections | 2 | 1985 | 365 | 0.020 |
Why?
|
| Sex Characteristics | 3 | 2012 | 2585 | 0.020 |
Why?
|
| Bacteria | 1 | 1979 | 2115 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 2126 | 0.020 |
Why?
|
| SEER Program | 1 | 2013 | 1507 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2009 | 8038 | 0.020 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1991 | 386 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 1993 | 1254 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2023 | 20130 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1997 | 3424 | 0.020 |
Why?
|
| Rural Population | 1 | 2018 | 2207 | 0.020 |
Why?
|
| Respiration Disorders | 1 | 1991 | 371 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 1998 | 1240 | 0.020 |
Why?
|
| Executive Function | 1 | 2016 | 1364 | 0.020 |
Why?
|
| Down Syndrome | 1 | 1976 | 880 | 0.020 |
Why?
|
| Lactation | 1 | 1990 | 412 | 0.020 |
Why?
|
| International Cooperation | 1 | 2014 | 1420 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 3873 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2020 | 2249 | 0.020 |
Why?
|
| Puberty | 1 | 2011 | 490 | 0.020 |
Why?
|
| Equipment Contamination | 1 | 1989 | 185 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3921 | 0.020 |
Why?
|
| Angina Pectoris | 3 | 1990 | 977 | 0.020 |
Why?
|
| Intrauterine Devices | 2 | 2007 | 122 | 0.020 |
Why?
|
| Mycoplasmatales Infections | 1 | 1987 | 19 | 0.020 |
Why?
|
| Utilization Review | 2 | 1979 | 392 | 0.020 |
Why?
|
| Serotonin | 1 | 1992 | 1017 | 0.020 |
Why?
|
| Hair Preparations | 1 | 1987 | 32 | 0.020 |
Why?
|
| Health | 1 | 2010 | 394 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2018 | 4026 | 0.020 |
Why?
|
| Death Certificates | 2 | 2004 | 169 | 0.020 |
Why?
|
| Tyramine | 1 | 1966 | 52 | 0.020 |
Why?
|
| Schools, Medical | 1 | 1993 | 881 | 0.020 |
Why?
|
| Lipoproteins, VLDL | 3 | 1996 | 201 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 1999 | 12961 | 0.020 |
Why?
|
| Reference Standards | 1 | 2010 | 1025 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 2513 | 0.020 |
Why?
|
| Drinking | 1 | 2007 | 197 | 0.020 |
Why?
|
| Universities | 3 | 2008 | 951 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 2011 | 2924 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 1993 | 1265 | 0.020 |
Why?
|
| Behavior, Addictive | 1 | 1992 | 462 | 0.020 |
Why?
|
| Constriction, Pathologic | 3 | 1995 | 1107 | 0.020 |
Why?
|
| Monoamine Oxidase | 1 | 1966 | 178 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2011 | 1536 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 1991 | 818 | 0.020 |
Why?
|
| Mice | 6 | 2016 | 81201 | 0.020 |
Why?
|
| Family Planning Services | 1 | 2008 | 263 | 0.020 |
Why?
|
| Contraceptive Agents, Female | 1 | 2007 | 135 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 1504 | 0.020 |
Why?
|
| Genetic Linkage | 3 | 2004 | 2421 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 8300 | 0.020 |
Why?
|
| Virus Replication | 1 | 2013 | 2535 | 0.020 |
Why?
|
| Nuclear Energy | 1 | 1985 | 14 | 0.020 |
Why?
|
| Cardiomegaly | 2 | 1985 | 620 | 0.020 |
Why?
|
| Fats, Unsaturated | 1 | 2005 | 21 | 0.020 |
Why?
|
| Hematuria | 3 | 1978 | 235 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1993 | 1873 | 0.020 |
Why?
|
| Cephradine | 1 | 1984 | 4 | 0.020 |
Why?
|
| Moxalactam | 1 | 1984 | 10 | 0.020 |
Why?
|
| Cefonicid | 1 | 1984 | 7 | 0.020 |
Why?
|
| Cefamandole | 1 | 1984 | 9 | 0.020 |
Why?
|
| Cephalothin | 1 | 1984 | 36 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2018 | 3680 | 0.020 |
Why?
|
| Chlamydia | 1 | 1985 | 33 | 0.020 |
Why?
|
| Nafcillin | 1 | 1984 | 25 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2014 | 1890 | 0.020 |
Why?
|
| Corneal Transplantation | 1 | 1989 | 386 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1998 | 2646 | 0.020 |
Why?
|
| Linoleic Acid | 2 | 2001 | 157 | 0.020 |
Why?
|
| Jaundice, Neonatal | 1 | 1985 | 71 | 0.020 |
Why?
|
| Job Description | 1 | 2004 | 58 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 4 | 1996 | 1681 | 0.020 |
Why?
|
| Endometriosis | 1 | 2013 | 839 | 0.020 |
Why?
|
| Ships | 1 | 1985 | 61 | 0.020 |
Why?
|
| New York City | 1 | 2007 | 710 | 0.020 |
Why?
|
| Rats | 4 | 2016 | 24252 | 0.020 |
Why?
|
| Asia, Southeastern | 1 | 2004 | 111 | 0.020 |
Why?
|
| Androstenols | 1 | 2004 | 25 | 0.020 |
Why?
|
| Methicillin | 1 | 1984 | 59 | 0.020 |
Why?
|
| Wine | 3 | 1993 | 165 | 0.020 |
Why?
|
| Pigmentation | 1 | 2005 | 148 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2010 | 1680 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1991 | 1813 | 0.020 |
Why?
|
| Coal | 1 | 2004 | 119 | 0.020 |
Why?
|
| Androstenedione | 1 | 2004 | 131 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2020 | 4687 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2265 | 0.010 |
Why?
|
| Language Tests | 1 | 1984 | 202 | 0.010 |
Why?
|
| Bone Density | 1 | 1997 | 3468 | 0.010 |
Why?
|
| Pharmacogenetics | 1 | 2008 | 674 | 0.010 |
Why?
|
| Hair | 2 | 2005 | 481 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2011 | 5181 | 0.010 |
Why?
|
| Color Perception Tests | 1 | 1983 | 14 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 1966 | 390 | 0.010 |
Why?
|
| PPAR gamma | 1 | 2007 | 493 | 0.010 |
Why?
|
| Drug Combinations | 2 | 2007 | 1958 | 0.010 |
Why?
|
| Proteinuria | 3 | 1978 | 658 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2007 | 570 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 4262 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1994 | 2708 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 1986 | 338 | 0.010 |
Why?
|
| Biological Availability | 1 | 2004 | 397 | 0.010 |
Why?
|
| Lod Score | 1 | 2004 | 614 | 0.010 |
Why?
|
| Intracranial Thrombosis | 1 | 2004 | 113 | 0.010 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2004 | 117 | 0.010 |
Why?
|
| Color Vision Defects | 1 | 1983 | 28 | 0.010 |
Why?
|
| Angiotensinogen | 1 | 1984 | 163 | 0.010 |
Why?
|
| Candidiasis | 1 | 2006 | 366 | 0.010 |
Why?
|
| Angiotensins | 1 | 1984 | 151 | 0.010 |
Why?
|
| Neisseria meningitidis | 2 | 1993 | 109 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 1 | 2004 | 252 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2011 | 4740 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2007 | 581 | 0.010 |
Why?
|
| Retirement | 1 | 2004 | 216 | 0.010 |
Why?
|
| Switzerland | 4 | 1991 | 256 | 0.010 |
Why?
|
| Atrial Fibrillation | 2 | 1992 | 5035 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1984 | 376 | 0.010 |
Why?
|
| International Normalized Ratio | 1 | 2004 | 367 | 0.010 |
Why?
|
| Fetal Heart | 1 | 1984 | 276 | 0.010 |
Why?
|
| Personnel, Hospital | 1 | 1985 | 283 | 0.010 |
Why?
|
| Heterozygote | 2 | 2007 | 2804 | 0.010 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2004 | 227 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 18034 | 0.010 |
Why?
|
| Maryland | 1 | 1983 | 276 | 0.010 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2006 | 245 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 707 | 0.010 |
Why?
|
| Growth Substances | 1 | 1985 | 784 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1989 | 1301 | 0.010 |
Why?
|
| Structure-Activity Relationship | 3 | 1993 | 3130 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 1987 | 2026 | 0.010 |
Why?
|
| Brain Infarction | 1 | 2004 | 299 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2018 | 3751 | 0.010 |
Why?
|
| Diet, Fat-Restricted | 1 | 2005 | 320 | 0.010 |
Why?
|
| Accidents, Aviation | 1 | 1981 | 14 | 0.010 |
Why?
|
| Private Practice | 1 | 1983 | 154 | 0.010 |
Why?
|
| Fibroblasts | 2 | 2011 | 4162 | 0.010 |
Why?
|
| Ear, Middle | 1 | 1984 | 334 | 0.010 |
Why?
|
| Seat Belts | 1 | 1981 | 57 | 0.010 |
Why?
|
| Chromatin | 1 | 2013 | 2933 | 0.010 |
Why?
|
| Pyridoxine | 1 | 1982 | 102 | 0.010 |
Why?
|
| Medicare | 1 | 2020 | 6566 | 0.010 |
Why?
|
| Apoptosis | 2 | 2014 | 9724 | 0.010 |
Why?
|
| Self Medication | 2 | 1981 | 117 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 1985 | 464 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 5172 | 0.010 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 1343 | 0.010 |
Why?
|
| Electrocardiography | 3 | 1983 | 6442 | 0.010 |
Why?
|
| Bulimia | 1 | 2003 | 383 | 0.010 |
Why?
|
| Bundle-Branch Block | 1 | 1983 | 270 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 1159 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7282 | 0.010 |
Why?
|
| Specimen Handling | 2 | 2004 | 694 | 0.010 |
Why?
|
| Pennsylvania | 5 | 1979 | 613 | 0.010 |
Why?
|
| Lipoprotein(a) | 1 | 2005 | 435 | 0.010 |
Why?
|
| Wisconsin | 1 | 2001 | 124 | 0.010 |
Why?
|
| Stents | 1 | 1993 | 3282 | 0.010 |
Why?
|
| Puerperal Infection | 1 | 1980 | 46 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 2 | 1984 | 1877 | 0.010 |
Why?
|
| Employment | 1 | 1987 | 1132 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 5321 | 0.010 |
Why?
|
| Fires | 1 | 1982 | 173 | 0.010 |
Why?
|
| Abortion, Induced | 2 | 1983 | 458 | 0.010 |
Why?
|
| Patella | 1 | 2002 | 320 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4468 | 0.010 |
Why?
|
| Antibodies, Bacterial | 4 | 1981 | 1470 | 0.010 |
Why?
|
| Morbidity | 1 | 1986 | 1768 | 0.010 |
Why?
|
| Apolipoproteins | 2 | 1993 | 317 | 0.010 |
Why?
|
| Aminoglycosides | 3 | 1988 | 162 | 0.010 |
Why?
|
| Hair Color | 2 | 1991 | 136 | 0.010 |
Why?
|
| Antigens, Bacterial | 2 | 1998 | 1172 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1983 | 931 | 0.010 |
Why?
|
| Daucus carota | 1 | 1999 | 10 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5867 | 0.010 |
Why?
|
| Upper Extremity | 1 | 2005 | 648 | 0.010 |
Why?
|
| Fluorescein Angiography | 2 | 2000 | 940 | 0.010 |
Why?
|
| Choroid | 1 | 1982 | 322 | 0.010 |
Why?
|
| Fundus Oculi | 2 | 1991 | 473 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2011 | 3476 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1984 | 2556 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2004 | 1216 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2007 | 1167 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 2001 | 505 | 0.010 |
Why?
|
| Sports Medicine | 2 | 1979 | 225 | 0.010 |
Why?
|
| Automobile Driving | 1 | 2005 | 431 | 0.010 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 1979 | 88 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 1984 | 926 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7658 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2012 | 2213 | 0.010 |
Why?
|
| Urethritis | 1 | 1978 | 23 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 2 | 1977 | 170 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 1981 | 279 | 0.010 |
Why?
|
| Retinaldehyde | 1 | 1998 | 25 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 1984 | 758 | 0.010 |
Why?
|
| Canada | 1 | 2004 | 2065 | 0.010 |
Why?
|
| Polymyxins | 1 | 1978 | 22 | 0.010 |
Why?
|
| Lipoproteins, LDL | 3 | 1991 | 640 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 1998 | 77 | 0.010 |
Why?
|
| Uterine Cervical Diseases | 1 | 1979 | 77 | 0.010 |
Why?
|
| Neomycin | 1 | 1978 | 88 | 0.010 |
Why?
|
| Specific Gravity | 4 | 1983 | 20 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1980 | 274 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2003 | 1460 | 0.010 |
Why?
|
| Lidocaine | 1 | 2002 | 544 | 0.010 |
Why?
|
| Graft Survival | 1 | 1989 | 3737 | 0.010 |
Why?
|
| X Chromosome | 3 | 1992 | 814 | 0.010 |
Why?
|
| Kidney Concentrating Ability | 2 | 1975 | 41 | 0.010 |
Why?
|
| Gardnerella vaginalis | 1 | 1977 | 13 | 0.010 |
Why?
|
| Cosmetics | 1 | 1979 | 97 | 0.010 |
Why?
|
| Operating Rooms | 1 | 1985 | 817 | 0.010 |
Why?
|
| Haemophilus | 1 | 1977 | 27 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 1999 | 379 | 0.010 |
Why?
|
| Marital Status | 1 | 1999 | 437 | 0.010 |
Why?
|
| Arginine | 1 | 1982 | 944 | 0.010 |
Why?
|
| Corynebacterium | 1 | 1977 | 47 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10483 | 0.010 |
Why?
|
| Wales | 1 | 1977 | 85 | 0.010 |
Why?
|
| Urogenital Neoplasms | 1 | 1979 | 137 | 0.010 |
Why?
|
| Drug Eruptions | 1 | 2000 | 297 | 0.010 |
Why?
|
| HIV-1 | 1 | 1995 | 6939 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1999 | 373 | 0.010 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 1998 | 107 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 2618 | 0.010 |
Why?
|
| Genitalia | 1 | 1978 | 112 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1979 | 567 | 0.010 |
Why?
|
| Expiratory Reserve Volume | 1 | 1976 | 9 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1997 | 242 | 0.010 |
Why?
|
| Cooking | 1 | 1999 | 313 | 0.010 |
Why?
|
| Kinetics | 2 | 1985 | 6476 | 0.010 |
Why?
|
| Hematocrit | 3 | 1983 | 636 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 1978 | 301 | 0.010 |
Why?
|
| Lower Extremity | 1 | 2005 | 1158 | 0.010 |
Why?
|
| Pulse | 3 | 1983 | 229 | 0.010 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 1978 | 257 | 0.010 |
Why?
|
| Night Blindness | 2 | 1991 | 53 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2002 | 1767 | 0.010 |
Why?
|
| Gonorrhea | 2 | 1978 | 335 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 1983 | 1173 | 0.010 |
Why?
|
| Cuba | 1 | 1996 | 47 | 0.010 |
Why?
|
| Tibia | 1 | 2002 | 1077 | 0.010 |
Why?
|
| Biological Transport | 1 | 1981 | 2120 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 21833 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2004 | 14561 | 0.010 |
Why?
|
| Social Adjustment | 1 | 1998 | 631 | 0.010 |
Why?
|
| Acetals | 1 | 1995 | 6 | 0.010 |
Why?
|
| Chlamydia trachomatis | 3 | 1985 | 246 | 0.010 |
Why?
|
| Liver | 3 | 1999 | 7475 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1975 | 173 | 0.010 |
Why?
|
| Self-Assessment | 1 | 1978 | 390 | 0.010 |
Why?
|
| Genome | 1 | 2004 | 1807 | 0.010 |
Why?
|
| Diuretics | 1 | 1998 | 591 | 0.010 |
Why?
|
| Neutropenia | 1 | 2000 | 895 | 0.010 |
Why?
|
| Sampling Studies | 2 | 1991 | 623 | 0.010 |
Why?
|
| Cholestyramine Resin | 1 | 1994 | 24 | 0.010 |
Why?
|
| Gemfibrozil | 1 | 1994 | 30 | 0.010 |
Why?
|
| Vitamin A Deficiency | 1 | 1995 | 101 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 2002 | 985 | 0.010 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1981 | 623 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2004 | 1903 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 1995 | 315 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 1978 | 532 | 0.010 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 1995 | 116 | 0.010 |
Why?
|
| Castration | 2 | 1987 | 159 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1999 | 1401 | 0.010 |
Why?
|
| Relaxation | 1 | 1974 | 50 | 0.010 |
Why?
|
| Inspiratory Capacity | 1 | 1993 | 36 | 0.010 |
Why?
|
| Premedication | 2 | 1989 | 258 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 2 | 1983 | 2269 | 0.010 |
Why?
|
| Hospitalization | 2 | 1986 | 10259 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1998 | 1525 | 0.010 |
Why?
|
| Immunization | 1 | 1998 | 1256 | 0.010 |
Why?
|
| Clindamycin | 2 | 1987 | 139 | 0.010 |
Why?
|
| Niacin | 1 | 1994 | 116 | 0.010 |
Why?
|
| Chlorine | 1 | 1993 | 50 | 0.010 |
Why?
|
| Decision Making | 1 | 2008 | 3888 | 0.010 |
Why?
|
| Yoga | 2 | 1974 | 253 | 0.010 |
Why?
|
| Virulence | 1 | 1997 | 1333 | 0.010 |
Why?
|
| Contraceptive Devices, Female | 2 | 1985 | 43 | 0.010 |
Why?
|
| Hydrogenation | 1 | 1993 | 21 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1997 | 1264 | 0.010 |
Why?
|
| Sex Chromosomes | 1 | 1974 | 105 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1993 | 349 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1993 | 414 | 0.010 |
Why?
|
| Erythema | 1 | 1994 | 257 | 0.010 |
Why?
|
| Student Health Services | 2 | 1985 | 41 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 1997 | 841 | 0.010 |
Why?
|
| Sulfur | 1 | 1993 | 166 | 0.010 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 1993 | 1018 | 0.010 |
Why?
|
| Preventive Medicine | 1 | 1994 | 264 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 1983 | 2732 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2000 | 1178 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1997 | 1586 | 0.010 |
Why?
|
| Potassium, Dietary | 1 | 1992 | 96 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1992 | 156 | 0.010 |
Why?
|
| Pravastatin | 1 | 1994 | 395 | 0.010 |
Why?
|
| Pregnancy Trimester, Third | 2 | 1987 | 571 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2002 | 2419 | 0.010 |
Why?
|
| Blood | 1 | 1975 | 598 | 0.010 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1992 | 90 | 0.010 |
Why?
|
| Florida | 3 | 1978 | 435 | 0.010 |
Why?
|
| Gentamicins | 2 | 1986 | 255 | 0.010 |
Why?
|
| Protein Binding | 1 | 1984 | 9384 | 0.010 |
Why?
|
| Hospitals, Veterans | 1 | 1994 | 404 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2000 | 1170 | 0.010 |
Why?
|
| Heart | 1 | 1985 | 4464 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2006 | 3020 | 0.010 |
Why?
|
| Estradiol Congeners | 1 | 1991 | 28 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1993 | 624 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1997 | 2726 | 0.010 |
Why?
|
| Platelet Function Tests | 1 | 1993 | 270 | 0.010 |
Why?
|
| Salmonella typhi | 1 | 1993 | 201 | 0.010 |
Why?
|
| Rabbits | 2 | 1989 | 4894 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1997 | 1539 | 0.010 |
Why?
|
| Basophils | 1 | 1994 | 389 | 0.010 |
Why?
|
| Salicylic Acid | 1 | 1991 | 56 | 0.010 |
Why?
|
| Color Perception | 1 | 1993 | 213 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1998 | 1516 | 0.010 |
Why?
|
| Candy | 1 | 1991 | 37 | 0.010 |
Why?
|
| Hip | 1 | 1992 | 257 | 0.010 |
Why?
|
| Temperature | 1 | 1998 | 2204 | 0.010 |
Why?
|
| Salicylates | 1 | 1991 | 126 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 1979 | 974 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 2005 | 2736 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 4463 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 1998 | 1425 | 0.010 |
Why?
|
| Mercury | 1 | 1993 | 285 | 0.010 |
Why?
|
| Polysomnography | 1 | 1997 | 1776 | 0.010 |
Why?
|
| Thinking | 1 | 1974 | 318 | 0.010 |
Why?
|
| Bacterial Vaccines | 1 | 1973 | 403 | 0.010 |
Why?
|
| Copper | 1 | 1993 | 366 | 0.010 |
Why?
|
| Skin Tests | 1 | 1993 | 613 | 0.010 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1993 | 578 | 0.010 |
Why?
|
| Prothrombin Time | 1 | 1990 | 119 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1979 | 2967 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 427 | 0.010 |
Why?
|
| Arsenic | 1 | 1993 | 328 | 0.010 |
Why?
|
| Cacao | 1 | 1991 | 98 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 5895 | 0.010 |
Why?
|
| Methylation | 1 | 1993 | 1106 | 0.010 |
Why?
|
| United States Department of Veterans Affairs | 1 | 1994 | 875 | 0.010 |
Why?
|
| Apolipoproteins B | 1 | 1992 | 374 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1978 | 2617 | 0.010 |
Why?
|
| Individuality | 1 | 1991 | 307 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1993 | 1892 | 0.010 |
Why?
|
| Forecasting | 1 | 1999 | 2951 | 0.010 |
Why?
|
| Ampicillin | 2 | 1979 | 139 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 1979 | 2108 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2004 | 4600 | 0.010 |
Why?
|
| Abortion, Spontaneous | 2 | 1985 | 544 | 0.010 |
Why?
|
| HIV Infections | 1 | 1995 | 16715 | 0.010 |
Why?
|
| Sepsis | 1 | 1983 | 2593 | 0.010 |
Why?
|
| Skin Pigmentation | 1 | 1991 | 282 | 0.010 |
Why?
|
| Culture Media | 2 | 1985 | 909 | 0.010 |
Why?
|
| Cephalosporins | 2 | 1979 | 204 | 0.010 |
Why?
|
| Urologic Diseases | 1 | 1991 | 244 | 0.000 |
Why?
|
| Chromosome Disorders | 1 | 1991 | 514 | 0.000 |
Why?
|
| Airway Resistance | 1 | 1989 | 404 | 0.000 |
Why?
|
| Streptococcus pneumoniae | 1 | 1993 | 714 | 0.000 |
Why?
|
| Maximal Expiratory Flow Rate | 1 | 1987 | 44 | 0.000 |
Why?
|
| Coronary Artery Bypass | 1 | 1997 | 2288 | 0.000 |
Why?
|
| Postal Service | 1 | 1988 | 96 | 0.000 |
Why?
|
| Placenta | 1 | 1977 | 1699 | 0.000 |
Why?
|
| Infection Control | 3 | 1979 | 965 | 0.000 |
Why?
|
| Myocardial Ischemia | 1 | 1998 | 2148 | 0.000 |
Why?
|
| Linoleic Acids | 1 | 1987 | 39 | 0.000 |
Why?
|
| Genetic Testing | 1 | 1980 | 3444 | 0.000 |
Why?
|
| Neisseria gonorrhoeae | 2 | 1981 | 238 | 0.000 |
Why?
|
| Serotyping | 2 | 1978 | 338 | 0.000 |
Why?
|
| Iproniazid | 1 | 1966 | 8 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 4805 | 0.000 |
Why?
|
| Polarography | 1 | 1966 | 10 | 0.000 |
Why?
|
| Sisomicin | 1 | 1986 | 6 | 0.000 |
Why?
|
| Netilmicin | 1 | 1986 | 8 | 0.000 |
Why?
|
| Immunoglobulin E | 1 | 1993 | 1463 | 0.000 |
Why?
|
| Amikacin | 1 | 1986 | 48 | 0.000 |
Why?
|
| Marriage | 2 | 1978 | 339 | 0.000 |
Why?
|
| Tobramycin | 1 | 1986 | 69 | 0.000 |
Why?
|
| Coronary Vessels | 2 | 1993 | 3107 | 0.000 |
Why?
|
| Genetics | 1 | 1987 | 112 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1998 | 9735 | 0.000 |
Why?
|
| Exercise Test | 1 | 1993 | 2073 | 0.000 |
Why?
|
| Occupational Medicine | 2 | 1977 | 115 | 0.000 |
Why?
|
| NADP | 2 | 1977 | 226 | 0.000 |
Why?
|
| Maine | 1 | 1985 | 139 | 0.000 |
Why?
|
| Oxygen Consumption | 2 | 1974 | 1868 | 0.000 |
Why?
|
| Enzymes | 1 | 1966 | 266 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1974 | 2969 | 0.000 |
Why?
|
| Triiodothyronine | 1 | 1966 | 494 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1966 | 1386 | 0.000 |
Why?
|
| Retinol-Binding Proteins | 1 | 1984 | 65 | 0.000 |
Why?
|
| Contraception Behavior | 1 | 1986 | 185 | 0.000 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 1983 | 74 | 0.000 |
Why?
|
| Terminology as Topic | 1 | 1991 | 1547 | 0.000 |
Why?
|
| Antibody Formation | 2 | 1979 | 1402 | 0.000 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1991 | 944 | 0.000 |
Why?
|
| Bundle of His | 1 | 1983 | 87 | 0.000 |
Why?
|
| Wechsler Scales | 1 | 1983 | 260 | 0.000 |
Why?
|
| Breech Presentation | 1 | 1983 | 44 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1975 | 2535 | 0.000 |
Why?
|
| Metacarpus | 1 | 1982 | 35 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1993 | 2509 | 0.000 |
Why?
|
| Thyroxine | 1 | 1966 | 667 | 0.000 |
Why?
|
| Extremities | 1 | 1988 | 866 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1985 | 2255 | 0.000 |
Why?
|
| Hearing | 1 | 1986 | 482 | 0.000 |
Why?
|
| Propranolol | 1 | 1984 | 502 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1997 | 6151 | 0.000 |
Why?
|
| Uveal Diseases | 1 | 1982 | 45 | 0.000 |
Why?
|
| Catholicism | 1 | 1982 | 30 | 0.000 |
Why?
|
| Skinfold Thickness | 1 | 1982 | 162 | 0.000 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 1983 | 140 | 0.000 |
Why?
|
| Ornithine | 1 | 1982 | 78 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 2 | 1987 | 1877 | 0.000 |
Why?
|
| Color | 1 | 1983 | 307 | 0.000 |
Why?
|
| Cough | 1 | 1985 | 555 | 0.000 |
Why?
|
| Cerebral Hemorrhage | 1 | 1993 | 2647 | 0.000 |
Why?
|
| Sympathetic Nervous System | 2 | 1974 | 513 | 0.000 |
Why?
|
| Trichomonas Vaginitis | 1 | 1981 | 35 | 0.000 |
Why?
|
| Vaccination | 1 | 1973 | 3279 | 0.000 |
Why?
|
| Obstetric Labor Complications | 1 | 1983 | 238 | 0.000 |
Why?
|
| Cornea | 1 | 1989 | 1524 | 0.000 |
Why?
|
| Vascular Resistance | 1 | 1983 | 936 | 0.000 |
Why?
|
| Nervous System | 1 | 1983 | 554 | 0.000 |
Why?
|
| Penicillin G | 1 | 1979 | 42 | 0.000 |
Why?
|
| Maximal Midexpiratory Flow Rate | 1 | 1979 | 78 | 0.000 |
Why?
|
| Nutritional Requirements | 1 | 1981 | 286 | 0.000 |
Why?
|
| Tetracyclines | 1 | 1979 | 60 | 0.000 |
Why?
|
| Israel | 1 | 1982 | 796 | 0.000 |
Why?
|
| Base Sequence | 1 | 1991 | 12797 | 0.000 |
Why?
|
| Pregnancy Trimester, First | 1 | 1983 | 853 | 0.000 |
Why?
|
| Anesthetics | 1 | 1985 | 539 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1985 | 1356 | 0.000 |
Why?
|
| Contraceptive Devices | 1 | 1978 | 24 | 0.000 |
Why?
|
| Vaginal Neoplasms | 1 | 1979 | 106 | 0.000 |
Why?
|
| Methylcholanthrene | 1 | 1978 | 29 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1990 | 3461 | 0.000 |
Why?
|
| Education | 1 | 1982 | 543 | 0.000 |
Why?
|
| Forms and Records Control | 1 | 1979 | 160 | 0.000 |
Why?
|
| Labor, Obstetric | 1 | 1982 | 333 | 0.000 |
Why?
|
| Methods | 1 | 1978 | 1129 | 0.000 |
Why?
|
| Vaginitis | 1 | 1977 | 47 | 0.000 |
Why?
|
| Enzyme Induction | 1 | 1978 | 475 | 0.000 |
Why?
|
| Aminophenols | 1 | 1978 | 78 | 0.000 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1980 | 347 | 0.000 |
Why?
|
| Wound Infection | 1 | 1979 | 242 | 0.000 |
Why?
|
| Genes, Dominant | 1 | 1980 | 880 | 0.000 |
Why?
|
| Sorbitol | 1 | 1977 | 59 | 0.000 |
Why?
|
| Deuterium | 1 | 1977 | 101 | 0.000 |
Why?
|
| Atrophy | 1 | 1982 | 1584 | 0.000 |
Why?
|
| Enterococcus faecalis | 1 | 1978 | 251 | 0.000 |
Why?
|
| Social Class | 1 | 1986 | 1997 | 0.000 |
Why?
|
| Penicillins | 1 | 1979 | 380 | 0.000 |
Why?
|
| Hand | 1 | 1982 | 884 | 0.000 |
Why?
|
| Contraceptive Agents | 1 | 1978 | 151 | 0.000 |
Why?
|
| Vulvar Neoplasms | 1 | 1979 | 272 | 0.000 |
Why?
|
| Fathers | 1 | 1979 | 358 | 0.000 |
Why?
|
| Leukemia | 1 | 1985 | 1510 | 0.000 |
Why?
|
| Urethra | 1 | 1978 | 408 | 0.000 |
Why?
|
| Liver Diseases | 1 | 1985 | 1253 | 0.000 |
Why?
|
| Urban Health | 1 | 1978 | 547 | 0.000 |
Why?
|
| Acetaldehyde | 1 | 1975 | 39 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1989 | 4397 | 0.000 |
Why?
|
| Antibody Specificity | 1 | 1978 | 1095 | 0.000 |
Why?
|
| Peptococcus | 1 | 1975 | 5 | 0.000 |
Why?
|
| Coloring Agents | 1 | 1978 | 566 | 0.000 |
Why?
|
| Propionibacterium | 1 | 1975 | 4 | 0.000 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1977 | 207 | 0.000 |
Why?
|
| Candida albicans | 1 | 1978 | 394 | 0.000 |
Why?
|
| Drug Resistance, Microbial | 1 | 1978 | 862 | 0.000 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1983 | 990 | 0.000 |
Why?
|
| Cervix Uteri | 1 | 1979 | 590 | 0.000 |
Why?
|
| Catalase | 1 | 1975 | 221 | 0.000 |
Why?
|
| Diet Fads | 1 | 1974 | 13 | 0.000 |
Why?
|
| Isotope Labeling | 1 | 1977 | 406 | 0.000 |
Why?
|
| Haplorhini | 1 | 1975 | 552 | 0.000 |
Why?
|
| Staphylococcus | 1 | 1975 | 155 | 0.000 |
Why?
|
| Streptococcus | 1 | 1975 | 197 | 0.000 |
Why?
|
| Quinacrine | 1 | 1974 | 24 | 0.000 |
Why?
|
| Social Conditions | 1 | 1974 | 126 | 0.000 |
Why?
|
| Molecular Conformation | 1 | 1975 | 562 | 0.000 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1979 | 582 | 0.000 |
Why?
|
| Anesthesia, Obstetrical | 1 | 1976 | 235 | 0.000 |
Why?
|
| Psychophysiology | 1 | 1974 | 135 | 0.000 |
Why?
|
| Bacteriological Techniques | 1 | 1975 | 277 | 0.000 |
Why?
|
| Membranes | 1 | 1974 | 173 | 0.000 |
Why?
|
| Emphysema | 1 | 1976 | 247 | 0.000 |
Why?
|
| Cell Nucleolus | 1 | 1974 | 166 | 0.000 |
Why?
|
| Fetal Death | 1 | 1975 | 448 | 0.000 |
Why?
|
| Vaginal Smears | 1 | 1975 | 511 | 0.000 |
Why?
|
| Airway Obstruction | 1 | 1976 | 664 | 0.000 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 1977 | 871 | 0.000 |
Why?
|
| Monitoring, Physiologic | 1 | 1979 | 1739 | 0.000 |
Why?
|
| Mouth Mucosa | 1 | 1974 | 434 | 0.000 |
Why?
|
| Kidney | 1 | 1986 | 7184 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1966 | 5709 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1975 | 2184 | 0.000 |
Why?
|
| Wakefulness | 1 | 1976 | 1245 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1977 | 2204 | 0.000 |
Why?
|
| Hypothalamus | 1 | 1974 | 1063 | 0.000 |
Why?
|
| Heart Ventricles | 1 | 1980 | 3817 | 0.000 |
Why?
|
| Delivery, Obstetric | 1 | 1975 | 906 | 0.000 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1979 | 2020 | 0.000 |
Why?
|
| Patient Discharge | 1 | 1979 | 3318 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1978 | 4217 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1974 | 1917 | 0.000 |
Why?
|
| Brain | 1 | 1983 | 26388 | 0.000 |
Why?
|